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ABSTRACT 
Rachel Candace Dirks 
 
THE INDIVIDUAL AND COMBINED EFFECTS OF EXERCISE AND 
COLLAGENASE ON THE RODENT ACHILLES TENDON 
 
 Tendinopathy is a common degenerative pathology that is characterized by 
activity related pain, focal tendon tenderness, intratendinous imaging changes, and 
typically results in changes in the histological, mechanical, and molecular properties of 
the tendon. Tendinopathy is difficult to study in humans, which has contributed to limited 
knowledge of the pathology, and thus a lack of appropriate treatment options. However, 
most believe that the pathology is degenerative as a result of a combination of both 
extrinsic and intrinsic factors.  
 In order to gain understanding of this pathology, animal models are required. 
Because each tendon is naturally exposed to different conditions, a universal model is not 
feasible; therefore, an appropriate animal model must be established for each tendon 
susceptible to degenerative changes. While acceptable models have been developed for 
several tendons, a reliable model for the Achilles tendon remains elusive. The purpose of 
this dissertation was to develop an animal model of Achilles tendinopathy by 
investigating the individual and combined effects of an intrinsic and extrinsic factor on 
the rodent Achilles tendon. 
 Rats selectively bred for high capacity running and Sprague Dawley rats 
underwent uphill treadmill running (an extrinsic factor) to mechanically overload the 
Achilles tendon or served as cage controls. Collagenase (intrinsic factor) was injected 
into one Achilles tendon in each animal to intrinsically break down the tendon. There 
were no interactions between uphill running and collagenase injection, indicating that the 
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influence of the two factors was independent. Uphill treadmill running alone failed to 
produce any pathological changes in the histological or mechanical characteristics of the 
Achilles tendon, but did modify molecular activity. Intratendinous collagenase injection 
had negative effects on the histological, mechanical, and molecular properties of the 
tendon.  
 The results of this dissertation demonstrated that the combined introduction of 
uphill treadmill running and collagenase injection did not lead to degenerative changes 
consistent with human Achilles tendinopathy. Intratendiouns collagenase injection 
negatively influenced the tendon; however, these changes were generally transient and 
not influenced by mechanical overload. Future studies should consider combinations of 
other intrinsic and extrinsic factors in an effort to develop an animal model that replicates 
human Achilles tendinopathy.  
   Stuart J. Warden, Ph.D., PT, Chair 
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CHAPTER ONE: INTRODUCTION 
 
1.1  Introduction 
 
The musculoskeletal system, consisting of bones, muscles, ligaments, and 
tendons, is a dynamic system that serves several functions in the body, including 
mechanical support, mineral homeostasis, hematopoiesis, and motion. For motion to 
occur, the connective tissue components (ligaments and tendons) are essential. To carry 
out this function, ligaments connect bone to bone and tendons connect muscle to bone. 
Tendons are dense bands of fibrous connective tissue that were originally thought to 
simply transmit forces. However, more recent research has revealed complex elastic 
functions of the tendon. Tendons are viscoelastic structures that undergo growth and 
remodeling in response to mechanical loading, but may be susceptible to pathology and 
injury as a result of a variety of factors. Although the understanding of tendons has 
advanced greatly, major voids in the knowledge of tendons remain. This lack of 
knowledge extends into the pathology, which has prevented the development of 
appropriate treatment options, and thus tendon pathology, once present, often persists 
throughout an individual’s life. Because of the limited number of studies pertaining to 
tendons and tendinopathy, discrepancies in findings are prevalent and there is a need for 
research on both the normal and pathological characteristics and functions of tendons.   
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1.2   Tendon anatomy and function 
 
1.2.1   Macroscopic tendon structure 
 
 Structurally, tendons have two points of attachment: the myotendionus junction 
(MTJ) between the tendon and muscle, and the osteotendionous junction (OTJ) between 
the tendon and bone. These attachments are referred to as the origin at the MTJ and 
insertion at the OTJ. At the origin, the collagen fibrils of the tendon protrude deep into 
the myofibroblasts, allowing forces generated by the contractile proteins of the muscle to 
be transmitted to the tendon collagen fibers [1-3]. This junction is the weakest point of 
the muscle-tendon unit [4,5]. There are two types of insertions, referred to as the fibrous 
enthesis and fibrocartilaginous enthesis, with the former describing the tendon attaching 
directly to the periosteum and the latter consisting of a transitional zone [6,7]. The 
transitional zone is an area where chondrogenesis has occurred and is composed of four 
different regions: dense, fibrous connective tissue; uncalcified fibrocartilage; calcified 
fibrocartilage; and bone. Although these four regions exist within the transitional zone, 
there are no distinct boundaries between regions, which instead appear as a gradual 
transition from tendon to calcified bone [8]. 
 Gross observation reveals a white color of tendons with variation in their shape, 
depending on the muscles and bones to which they attach. Typically, the tendons of more 
powerful muscles are short and broad, while tendons of muscles performing more 
delicate movements are long and slender. Tendons may also be surrounded by a 
combination of other structures, depending upon their location and function. Many 
structures exist to reduce friction as the tendon moves through its course, including 
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retinacula, reflection pulleys, synovial sheaths, peritendinous sheaths, and tendon bursae. 
Retinacula are the canals through which tendons move, and reflection pulleys reinforce 
the retinacula along curves in order to keep the tendon on its proper course. Synovial 
sheaths consist of multiple layers and contain peritendinous fluid to prevent friction. 
These sheets are quite rare, and instead, most tendons have peritendinous sheets 
(paratenon). The paratenon is made of loose fibrillar tissue and prevents the tendon from 
moving against surrounding tissues. Finally, the tendon bursae exist to prevent bony 
prominences from compressing the tendon. 
 
1.2.2   Microscopic tendon structure 
 
 Tendons, much like muscle, are organized into a hierarchical structure of fibrils, 
fibers, and fiber bundles which ultimately form the gross tendon structure. Most tendons 
are surrounded by the paratenon, which consists of type I collagen, type III collagen, and 
elastic fibrils, along with a lining of synovial cells on its inner surface [9-11]. Under the 
paratenon lies the epitenon, which is a thin connective tissue sheath surrounding the 
entire tendon. The epitenon is made of longitudinal, oblique, and transverse collagen 
fibrils, which exhibit uniform density and organization and may also fuse to superficial 
tendon fibrils [12]. The endotenon lies under the epitenon and surrounds each tendon 
fiber and fiber bundle [12,13]. This layer is made of collagen fibrils in a crisscross pattern 
[13-15] and carries vessels, nerves, and lymphatics into the tendon [13,16]. 
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a)  Tendon cells 
 
 Tenoblasts and tenocytes, which are homologous to fibroblasts and fibrocytes, 
comprise the majority of tendon cells. These cells lie between the collagen fibers and are 
responsible for production of the extra-cellular matrix (ECM) [16]. In addition, 
chondrocytes may be found near the insertion, synovial cells are located in the tendon 
sheath, and cells associated with vascularity (endothelial and smooth muscle cells) are 
located in the endo- and epitenon. More recently, tendon stem cells (TSCs) have been 
identified in mice, rats, rabbits, and humans [17-20]. TSCs are able to self-renew, as well 
as differentiate into adipocytes, chondrocytes, osteocytes, and tenocytes [19]; therefore 
TSCs are important for tendon maintenance and repair [21]. 
 While adult tendons have minimal cellularity, immature tendons have a much 
greater number of cells. The tenoblasts found in newborn tendons are arranged in long, 
parallel chains and vary in shape and size, including long, round, and polygonal [22]. 
These cells are responsible for the formation of the ECM and their composition enables 
the high metabolic activity responsible for the synthesis of the matrix. This includes well 
developed rough endoplasmic reticulum (ER), Golgi apparatus, and long, slender 
cytoplasmic processes forming desmosomal, tight, and gap junctions between cells 
[22,23]. The rough ER and Golgi apparatus are vital in the production of proteoglycans 
and glycoproteins found in the ECM, with the protein being formed in the rough ER and 
the glycidic portion in the Golgi apparatus [24]. The intercellular junctions are important 
as they are likely involved in coordinating the response to loading of the tendon [25]. 
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 With aging, the number of cells decreases as the amount of matrix increases. 
During this process, the majority of tenoblasts become tenocytes, as they elongate and 
undergo changes in composition, leaving them with a nucleus and very little cytoplasm. 
The elongation is believed to allow for continued contact between the cells and matrix as 
the number of cells decreases [23]. Because these cells are still metabolically active, the 
rough ER and Golgi apparatus remain well-developed [26].  
 
b)  Extracellular matrix  
 
 The main function of the extracellular matrix (ECM) is structural support of the 
tendon during the transmission of force in the muscle-tendon complex. This strength is 
dependent on the intra- and intermolecular cross-links and the orientation, density, and 
length of the collagen fibers. Turnover of the ECM is influenced by physical activity with 
more turnover existing in tendons that undergo regular physical activity and inactivity 
leading to decreased ECM turnover [27]. Collagen makes up the majority of the ECM, 
but the strength is dependent upon the coordination of collagen with many other 
molecules, including elastic fibers, ground substance, and inorganic components.  
 
Collagen- Tendons are composed of 65-80% collagen and 1-2% elastin within a 
proteoglycan-water matrix [28-31]. Of the collagen, approximately 90% is type I, less 
than 10% is type III, and the remainder is any combination of the other forms of collagen 
[32]. The basic unit of collagen is the α chain, which is a repeating triplet of amino acids 
(Glycine-X-Y), where X and Y are often proline and hydroxyproline, which contribute to 
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the rigidity of collagen, as areas lacking proline and hydroxyproline have more flexibility 
[33,34]. Three α chains then combine to form a triple helix called procollagen, which is 
roughly 1000 amino acid residues with a length of about 300 nm [35]. The procollagen 
molecule contains non-helical extensions at each end [36,37], named the amino- (N) and 
carboxylic- (C) propeptides. The N- and C- propeptides are removed by proteinases prior 
to the final collagen fibril assembly [38]. Collagen molecules assemble into five row 
microfibrils, which range from 20 to 280 nm in diameter [39], with larger diameters 
typically in mature or large tendons. In this configuration, collagen molecules align end-
to-end in a staggered pattern leaving a 67 nm gap zone between ends [35] (Figure 1.1). 
This arrangement leads to the banding pattern that is visible under magnification. 
Additionally, a crimping pattern is visible under magnification in several tendons [40,41]; 
however, the geometry of the pattern differs between tendons. 
Once in this arrangement, cross-linking can occur between collagen molecules, 
which affect the overall strength of the collagen. Enzymatic cross-links include 
lysylpyridinoline, which exist in small quantities near the bone insertion [42,43] and 
hydroxylysylpyridinoline, which are increased in older tendons [44] and tendons 
undergoing greater mechanical stresses [45]. Non-enzymatic cross-linking may also 
occur, resulting in irreversible binding of sugars to matrix proteins [42].   
The collagen fibrils form the base of the hierarchical structure of the tendon and 
aggregate to form collagen fibers. The collagen fibers combine to form a primary fiber 
bundle (subfascicle), which in turn, combine to form a secondary fiber bundle (fascicle). 
Finally, the fascicles congregate to form a tertiary bundle, and the tertiary bundles make 
up the tendon (Figure 1.2). 
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Figure 
1.1. Structural hierarchy of collagen (Reproduced from Orgel, et al. [46] with 
permission from Elsevier). 
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Figure 1.2. The organization of tendon structure (Reproduced from Kannus 
[26] with permission from John Wiley and Sons). 
 
Ground substance- In tendons, the ground substance surrounds the collagen and 
consists of proteoglycans, glycosaminoglycans (GAGs), structural glycoproteins, and a 
variety of other molecules. Proteoglycans are defined by a protein core covalently bonded 
to one or more GAGs. They are negatively charged, hydrophilic molecules and are 
typically located within and between collagen fibrils and fibers [26]. Because of their 
charge, proteoglycans are stiff and resistant to compressive and tensile forces. The 
amount of proteoglycan within tendon is dependent upon mechanical loading conditions 
of the tendon, with tendons undergoing greater loads having greater amounts of 
proteoglycans [47-50]. Examples of proteoglycans within tendons are aggrecan, which 
holds water and resists compression [50] and decorin, which enables sliding of the fibrils 
during mechanical deformation [51]. Additionally, proteoglycans may inhibit 
calcification of the tendon by filling the gap zones between collagen fibrils where 
minerals are able to deposit [52].  
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Glyocoproteins are groups of proteins with a carbohydrate component and are 
able to bind macromolecules or cell surfaces together. Fibronectin, thrombospondin, 
tenascin-C, and undulin are examples of glycoproteins that have been identified in 
tendons [53-55], with fibronectin facilitating wound healing [56,57] and all glycoproteins 
interacting with collagen fibrils to increase mechanical stability of the ECM [58].  
 
Elastic fibers- Elastic fibers are sparse within tendons and are estimated to only 
account for 1-2% of the dry weight [29]. This percentage may be even less in humans, as 
Jozsa and Balint [59] found measurable amounts of elastic fibrs in only 10% of healthy 
human tendons. However, the number and volume of elastic fibers in tendons are 
increased in patients with certain diseases, such as Ehlers-Danlos syndrome and chronic 
uremia [59,60]. 
Elastic fibers consist of two distinct components: elastin and microfibrils. Elastin 
forms the central core, which comprises about 90% of the elastic fiber. The microfibrils 
have a diameter of 10-12 nm and form a sheath that surrounds the elastin central core 
[61]. Once formed, the elastic fibers are oriented parallel to the basic tissue organization 
of the tendon [62]. These fibers are found in many tissues, including arteries, lungs, 
cartilage, and connective tissue and have a primary function of recoil, allowing the elastic 
tissues to undergo repeated stretch and relaxation cycles [62]. Aside from this main 
function, the specific function of elastic fibers in tendons is unclear, but they are thought 
to contribute to the recovery of the wavy configuration of the collagen fibers after the 
tendon is released from a stretch [63]. 
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Inorganic elements- Inorganic components are very scarce in tendons, but a 
variety have been detected [64,65], with calcium being the most common. These 
elements are usually found in limited quantities but may function in growth, 
development, and normal metabolism of musculoskeletal structures [66,67]; however, the 
actual role of many of these elements is unknown. 
 
1.2.3   Tendon metabolism 
 
Tenocytes are capable of the aerobic Krebs cycle, pentose phosphate pathway, 
and anaerobic glycolysis, all of which are pathways of energy metabolism necessary for 
energy production and biosynthesis of the matrix [30,31,60,68]. The ratio of the 
utilization of these pathways changes during growth of the tendon, as the three pathways 
are highly active in immature tendons, but only anaerobic glycolysis remains active in 
adult tenocytes. Therefore, the metabolic pathways of tendons become more anaerobic 
with age [16,69]. Also changing with age is the synthetic activity, as growing tendons are 
actively synthesizing collagen, elastic fibers, proteoglycans, and glycoproteins, but this 
activity decreases with age  [70]. 
 Little is known about the metabolism of the tendon matrix with the exception of 
collagen. Similar to the other tendon characteristics, collagen metabolism changes with 
age. The rate of collagen production is very high in infancy and drastically reduces as the 
tendon ages. The rate of collagen turnover remains low throughout adulthood with only 
areas of newly synthesized collagen being metabolically active [71]. 
Even less is known about matrix catabolism, but using knowledge of other 
connective tissue degradation, it may occur in two ways: 1) lysosomes or cytoplasmic 
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degradative enzymes are produced by tenocytes and secreted into the ECM, and 2) 
degradation through phagocytosis and pinocytosis [26]. 
 The combination of the low metabolic rate and anaerobic metabolism is crucial 
for the tendon to effectively carry out its function of carrying loads and remaining in 
tension for long periods, as they can continue to function with little or no oxygen. 
However, this combination also has a negative impact of lengthening recovery and 
healing times after activity or injury [11,72]. This consequence is twofold, because 
oxygen is required for the synthesis of collagen [73,74] and the low metabolic rate 
prevents quick repair of any damage done to the tendon, which may be further aggravated 
by activity prior to full recovery.  
 
1.2.4   Tendon function and biomechanics 
 
Historically, tendons were simply described as transmitting forces from muscle to 
bone, allowing for motion of the bone. More recently, research has focused on the effect 
of tendon elasticity on motion. 
 
a)  Elasticity 
 
Tendons function as springs, which are defined by deforming when a force is 
applied and recoiling to the resting shape when the force is released. During deformation, 
the material of a spring stores energy in the form of elastic strain energy, which is 
released when the spring recoils. The amount of energy that is stored depends on the 
stiffness of the material and the deformation of the material. Furthermore, the spring 
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cannot produce additional energy, it may only release the energy loaded by the external 
source. While this action of a spring appears relatively simple, the springing action of 
tendons serves many functions, including conservation of energy, amplification of muscle 
power output, and attenuation of muscle power input [75]. 
First, in birds and moderately large animals, including humans, tendons decrease 
the amount of metabolic energy required for locomotion. For example, the Achilles 
tendon undergoes stretch and recoil as the ankle flexes and extends, allowing the muscles 
to remain at a constant length, thus decreasing the amount of work required by the 
muscles [76,77]. This action may also benefit animals when swimming or flying, as the 
tendons may lead to energy savings as the fins, tails, or wings undergo repeated 
acceleration and deceleration [78]. However, this benefit is lessened in smaller animals, 
as their Achilles tendons undergo very little stretch, requiring the muscles to do more 
work [79].  
Second, tendons have accelerated recoil and can amplify muscle power, which is 
beneficial in many ways, including enhanced jumping ability. When muscles contract 
quickly, they exert less force [80], but tendons are able to amplify muscle power output 
by storing the muscle work slowly and releasing it rapidly. The energy released by the 
tendon is roughly equal to the overall amount of work done by the muscle during 
contraction, but it is released in a shorter amount of time. Because power = work/time, 
this leads to power output that exceeds the capacity of the muscle [75]. Since tendons can 
recoil faster than muscles are able to shorten [81], animals are able to maximize the 
power from the muscle and thus jump higher and further [82-84]. This amplification of 
muscle power in jumping has been observed in many animals, including frogs [84,85], 
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bushbabies, [86], birds [87], and humans [88]. Additionally, this muscle power 
amplification can be observed in accelerating animals, such as turkeys [89] and horses. 
For example, in horses, the power output of the biceps brachii is amplified more than 50 
times during rapid bursts [90]. 
Tendons also contribute to the attenuation of mechanical power produced by 
muscles. Studies on isolated muscle-tendon units and in vivo studies have both revealed 
that when muscle-tendon units are rapidly stretched, the tendon may stretch, while the 
muscle remains at either the same or a reduced length [91,92]. This stretching of the 
tendons likely plays a protective role for the muscles, which are susceptible to damage 
when fibers are actively lengthened [93,94]. However, because tendons are springs, they 
are unable to absorb the energy during stretch, only store it temporarily. Similar to the 
power amplification by tendons, this temporary storage of the power allows the muscle to 
absorb the energy more slowly, leading to an overall absorption of energy beyond the 
muscle’s maximum capacity for energy absorption [75]. 
It is important to note that while the elasticity of tendons is primarily beneficial, 
the work they do may lead to overheating. Approximately 93% of the work done by 
tendons during stretching is returned during recoil, with the remaining 7% being 
dissipated as heat [78]. Because tendons have very little vascularity, this heat is not easily 
dissipated, and when an animal performs excessive repeated movements, this may lead to 
heat damage of the tendon [81,95]. 
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b)  Stiffness 
 
The stiffness of an object describes its rigidity, or the extent to which it resists 
deformation in response to an applied force. Stiffness can be measured by calculating the 
slope of a force-displacement curve and represents the ratio of force applied to the tendon 
to its elongation in response to the force. Tendon stiffness is dependent upon the location 
and function of the tendon and may be influenced by tendon length and cross-sectional 
area (CSA). For example, a shorter tendon with a larger CSA would likely have greater 
stiffness, but the actual relationship between tendon morphology and stiffness is unclear 
[96]. In order to determine tendon mechanical properties independent of the geometric 
characteristics, Young’s modulus can be calculated. Young’s modulus is calculated by 
dividing tensile stress by tensile strain in the linear region of the stress strain curve and 
provides a measure of stiffness normalized to tendon CSA and length [97]. 
Stiffness is an important factor in the mechanical properties of the tendon, having 
a significant influence on force transmission and muscle power. To demonstrate this, 
Bojsen-Moller, et al. [98] investigated the relationship between the mechanical properties 
of tendon and muscle performance of the vastus lateralis muscle-tendon unit. Participants 
performed squat jumps and the researchers found correlation between the tendon stiffness 
and the power, force, and velocity of the jumps. This indicated that muscle output is 
positively correlated to the tendon stiffness, and the group hypothesized that increased 
stiffness allows for more effective force transmission. Therefore, an optimal level of 
tendon stiffness is essential for effective muscle-tendon interactions.  
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Tendons may undergo remodeling to ensure that the stiffness is optimized for that 
muscle-tendon unit, as studies have shown increased tendon stiffness in response to long 
term exercise [99-101]. Reeves, et al. [101] conducted a study investigating the effect of 
strength training on patellar tendon stiffness and found that leg extension and leg press 
exercises increased tendon stiffness by 65%. This increased stiffness resulted in a 
reduction in tendon elongation and strain, which decreases the possibility of tendon 
injury. While tendon stiffness does increase with exercise, it is unknown whether this 
change in stiffness is due to changes in tendon dimension, material properties, or both 
[99,102,103]. 
 
c)  Strain 
 
Strain is a measure of deformation of the tendon. Because tendons are viscoelastic 
tissue, they are sensitive to different strain rates. At low strain rates, the tendons absorb 
more energy but are less effective at transferring loads, while at high strain rates, they are 
less deformable but are more effective at transferring loads [104].  
Strain is typically presented as a stress-strain curve, which depicts the amount of 
deformation (strain) at specific levels of tensile loading (stress). Stress (σ) is defined as 
the ratio of force (F) to the CSA (A) (σ = F/A). Stress-strain curves provide many 
important details about the mechanical properties of the tendon and have four distinct 
regions (Figure 1.3): 
1) Toe region - the tendon is strained up to 2%.  In this region, the crimp pattern 
of the tendon is stretched out. This crimp pattern provides insight into the 
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mechanical properties of the tendon, as tendons with a small crimp angle fail 
before those with a larger crimp angle. Differences in the crimp pattern exist 
in different types of tendons and different sites within the same tendon [105]. 
2) Linear region - the tendon is strained up to 4%, resulting in a loss of the 
crimp pattern. The Young’s modulus is calculated from the slope of this 
region and represents the stiffness of the tendon. 
3) Microscopic tearing - the tendon is strained above 4%.  
4) Macroscopic failure – the tendon is strained beyond 8-10%.  If the tendon 
undergoes further stretching, rupture will occur [63]. However, some tendons 
may be able to withstand much greater stresses, including the avian flexor 
tendon, which can be stretched up to 14% [106]. 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Tendon stress-strain curve (Reproduced from Wang [107] with 
permission from Elsevier). 
 
Previous studies have been done on various tendons in both humans and animals 
and have found great variation in mechanical properties according to tendon location and 
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age. For example, the human patellar tendon has a Young’s modulus of 660 ± 226 MPa 
in young donors and 504 ± 222 MPa in older donors [108]. Conversely, the anterior 
tibialis tendon has a Young’s modulus around 1200 MPa [109]. 
 
1.3   Human tendon pathology 
 
1.3.1   Pathology 
 
Tendinopathy (tendo– = tendon, –pathy = disease) is characterized by activity-related 
pain, focal tendon tenderness, and intratendinous imaging changes [110] and typically 
results in changes in the histological, mechanical, and molecular properties of a tendon. 
Much debate has existed in the classification and nomenclature of tendinopathies. 
“Tendinitis”, or inflammation of the tendon, has been commonly used to describe tendon 
disorders; however, after many histological studies, this term is now believed to be 
inaccurate. Puddu et al [111] originally used the term “tendinosis”, or degradation of the 
tendon, to describe the tendon pathology. Kannus and Jozsa [69] later conducted an 
intensive study of human tendon histology and supported the use of tendinosis, finding 
that pathological tendons presented with degenerative, rather than inflammatory changes. 
Other studies have found that inflammation is infrequent and typically only occurs in 
cases of tendon rupture [112-115]. Therefore, tendinopathies are now widely regarded as 
“tendinosis” rather than “tendinitis”. 
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a)  Histological changes  
 
Macroscopically, the degenerated areas of tendons appear soft, gray or yellow, 
and non-glistening [116]. Using light microscopy, tendinosis appears as changes in 
collagen, ground substance, and tenocytes. Collagen fibers lose their normal crimping 
pattern and undergo separation, losing their proper orientation. They may also exhibit 
decreased fiber diameter and density [104]. Furthermore, microtearing may occur 
throughout the tendon and an increase in the mucoid ground substance may exist in 
pathological tendons [117,118]. 
 Cellularity and tenocyte morphology are variable in tendinosis. Pathological 
tendons may have tenocytes which are overly abundant, have rounded nuclei and an 
abundance of cytoplasm or they may be acellular and appear necrotic or apoptotic [104]. 
While there is variation in cellularity, an increase in vascularity is a hallmark feature in 
tendinosis. However, there is rarely an infiltration of lymphocytes, macrophages, or 
neutrophils [104]. 
 Histological assessment is a standard method of evaluation for tendon research in 
both humans and animals [119]. The most widely accepted method of histopathological 
quantification is the Bonar score; however much variation exists in the characteristics 
analyzed as part of the score. For example, Maffulli, et al. [113] assessed fiber structure, 
fiber arrangement, rounding of the nuclei, regional variations in cellularity, increased 
vascularity, decreased collagen stainability, hyalinization, and GAG content on a scale 
from 0 to 3, with 0 being normal and 3 being the most abnormal. In contrast, Cook, et al. 
[120] condensed the analysis to only 4 categories: tenocyte morphology, ground 
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substance, collagen arrangement, and vascularity. Again, these categories were scored 
from 0-3, with 0 being normal and 3 being abnormal. Scott, et al. [121] assessed tenocyte 
morphology, tenocyte proliferation, collagen organization, GAGs, and neovascularization 
on a scale of 0 to 4, with 0 being normal and 4 being abnormal. Most recently, Fearon et 
al. [122] have conducted a study analyzing the variations in tendon histological 
assessment and evaluated the tendon cell morphology, collagen arrangement, cellularity, 
vascularity, and ground substance. These characteristics were graded from 0 to 3 with 0 
being normal and 3 being abnormal. In addition, this study improved the standardization 
of the Bonar scale by investigating which area of the tendon should be assessed. Previous 
studies simply reported that the most pathological region of the tendon was assessed, 
which is difficult to reproduce. The study conducted by Fearon et al. evaluated which of 
the assessed characteristics should be used to define the most pathological region and 
concluded that scores measuring pathology were highest when assessing the area of worst 
cell morphology or collagen disruption. Furthermore, the study included a more specific 
description of how the tendon should be assessed by defining both the magnification and 
number of fields of view that should be analyzed for each category.  
 
b)   Mechanical changes 
 
The mechanical properties of tendons are directly related to the arrangement of 
collagen fibers within the tendon [35]; therefore, it is expected that the altered collagen 
structure and arrangement in tendinosis would result in altered mechanical properties 
[107]. Studies analyzing the mechanical properties of tendinopathy are more limited than 
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those focusing on the histological presentation. Arya and Kulig [97] performed a study 
using real-time ultrasound imaging and dynamometry to assess the stiffness, Young’s 
modulus, stress, strain, and CSA of pathologic Achilles tendons. They found that 
tendinopathic tendons had decreased stiffness and Young’s modulus, and increased CSA. 
While an increased CSA is typically an indication of increased strength, the decreased 
Young’s modulus and stiffness of these tendons indicate alterations in the tendon 
composition and structure. Specifically, the increased CSA is the result of several factors, 
including accumulation of water and ground substance [123], increased separation, 
crimping, and tearing of type I collagen, and increased levels of type III collagen [124]. 
Together, these changes lead to an increased CSA while weakening the mechanical 
properties of pathologic tendons. 
 
c)  Molecular changes 
 
No definitive summary of gene expression in tendinopathy has been developed; 
however, many studies have had common findings when investigating mRNA expression 
in healthy versus pathological tendon tissue. Two of the most commonly studied genes 
are collagen and matrix metalloproteases (MMPs). Collagen is the major constituent in 
tendon tissue, with type I collagen being dominant. Type III collagen is typically present 
in low quantities, but in pathological tendons, both type I and type III collagen are 
increased [125-128]. MMPs are a group of zinc and calcium dependent endopeptidases 
which are responsible for ECM remodeling. They can be divided into four main groups: 
collagenases, which cleave types I, II, and III collagen; gelatinases, which cleave type IV 
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and denatured collagens; stromelysins, which degrade proteoglycans, fibronectin, casein, 
and types III, IV, and V collage; and membrane-type MMPs [129]. In tendons, MMP-1, -
2, -3, and-13 have been found to be altered in tendinopathy. Of these, MMP-1 and -13 are 
collagenases, MMP-2 is a gelatinase, and MMP-3 is a stromelysin. MMP-1 and MMP-13 
are upregulated in tendionpathy and tendon tears [130,131]. MMP-2 is also upregulated 
in tendinopathy [125,127,128,132], but may be upregulated or downregulated in tendon 
tears [133]. MMP-3 is downregulated in tendinopathy and tendon tears [125-128,130-
132,134,135]. Therefore, the four groups of MMPs may have different effects on the 
tendon. 
 The activity of MMPs is inhibited by tissue inhibitors of metalloproteases 
(TIMPs) and the balance between MMP and TIMP activity regulates the remodeling of 
tendons. TIMPs inhibit MMPs by binding to the active site of MMPs, thus preventing the 
MMP from cleaving their particular substrates [136,137]. There are four types of TIMPs, 
TIMP-1, -2, -3, and -4, and all have been found to be downregulated in tendinopathy, 
with variable levels in tendon tears [127,131,133,138]. 
 Transforming growth factor β (TGFβ) has been implicated in tendinopathy, as it is 
known to be a mediator of mechanically induced collagen synthesis in many different cell 
types [139-143]. In addition, connective tissue growth factor (CTGF) may play a role 
similar to TGFβ [144,145]. Studies typically examine the effect of loading on TGFβ and 
CTGF, with some reporting decreases in both TGFβ and CTGF [146], some finding 
increased levels of TGFβ [147,148] and CTGF [149], and others reporting no changes in 
TGFβ [150] or CTGF [148,150] following loading. Heinemeier et al. [146] speculate that 
these differences are due to short-term versus long-term loading, and hypothesize that 
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initial increases in TGFβ and CTGF exist, but then reduce once a steady state is reached. 
Therefore, short-term loading would result in increased levels and long-term loading 
would result in normal or decreased levels.   
 Vascularity of tendons varies by region on the tendon [151-156], but is typically 
minimal because of the few metabolic requirements of tendons [104]. The formation of 
new blood vessels, or angiogenesis, is controlled by the balance between stimulatory and 
inhibitory molecules, vascular endothelial growth factor (VEGF) and endostatin, 
respectively [157,158]. In normal adult tendons, endostatin, the anti-angiogenesis factor, 
is predominantly expressed [159], while fetal tendons express more VEGF [156,160]. 
Endostatin is a 20 kDa, C-terminal fragment of type XVIII collagen, which acts in several 
ways to inhibit angiogenesis, including inhibiting proliferation and migration of 
endothelial cells required for new vessels [161] and inhibiting VEGF signaling [162]. 
VEGF is a family of growth factors that result from alternative splicing of the VEGF 
gene. These growth factors work through a tyrosine kinase pathway to initiate 
angiogenesis. Because neovascularization is observed in tendinosis [163], increased 
levels of VEGF and decreased levels of endostatin are associated with degenerative 
tendons. Additionally, VEGF may have another role in tendon degeneration, as it is able 
to upregulate the expression of MMPs and downregulate the expression of TIMPs, 
leading to increased collagen degradation [164-166] 
 Scleraxis (Scx) has recently been identified as a regulator of embryonic tendon 
[167-169] by encoding for a transcription factor present in tendon progenitor cells during 
development through adulthood [168,169].  In tenocytes, Scx regulates transcription of 
type I collagen [170]. Further studies have revealed that scleraxis is coordinately 
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expressed in tendons after injury in animal models [171-173] and levels are increased 
following mechanical loading [174,175] and decreased following tendon unloading 
[174]. Therefore, scleraxis may play an important role in the adaptation to mechanical 
loading in tendons.  
In addition to the aforementioned genes, inflammatory molecules and pathways 
may also have a role in tendinosis. Although tendinosis is degeneration rather than 
inflammation of the tendon, many groups have reported the presence of inflammatory 
markers, typically in the very early stages of pathology. Examples of inflammatory 
mediators are leukotrienes and prostaglandins, which are lipid molecules with autocrine 
and paracrine signaling capabilities. These molecules have many effects throughout the 
body; however, the effect most relevant to tendinopathy is the regulation of 
inflammation. Prior to examining the effects of inflammatory mediators in tendinopathy, 
it is important to understand their synthesis pathways (Figure 1.4). To begin, 
phospholipids are hydrolyzed by phospholipase A2 (PLA2), releasing arachidonic acid 
and lysophospholipids. Arachidonic acid is then converted to either endoperoxides or 
arachidonic acid 5-hydroperoxide (5-HPETE) by cyclooxygenase (COX) or 5-
lipoxygenase (5-LO) and 5-lipoxygenase-activating protein (FLAP), respectively. 
Endoperoxides are then converted to prostaglandins and 5-HPETE is converted to 
leukotrienes. A specific prostaglandin of interest is prostaglandin E2 (PGE2), which is 
also a potent inhibitor of type I collagen synthesis, leading to catabolic effects on the 
tendon structure [176-178].  
There is a lack of consensus regarding any of these mediators and intermediate 
molecules in tendon pathology. Many in vitro studies have reported increased levels of 
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these molecules after mechanical deformation, including cytosolic and secretory PLA2 
[179], COX-1 and -2 [179,180], PGE2 [180,181], 5-LO, and leukotriene B4 (LTB4) [182]. 
In addition, Fu, et al. [183] examined human tendinosis biopsies and in vitro tendinosis 
cultures and found increased expression of COX-2 and PGE2. Other studies, however, 
have reported no increases in PGE2 with in vivo microdialysis [184] or in cultured 
tendinosis specimens [185]. These contradictory findings contribute to the ongoing 
debate of inflammation versus degradation in tendinopathy and may be due to different 
processes occurring at different time points or locations of pathology in the tendons.  
Figure 1.4. Synthesis pathway of inflammatory mediators. 
  
Cytokines assosicated with inflammation, specifically interleukins (IL) and tumor 
necrosis factors (TNF), have also been investigated in tendinopathies. These cytokines 
are part of intricate inflammatory signaling pathways and also impact the prostaglandin 
pathway, as IL and TNF increase COX, and thus PGE2 levels [186]. There is much 
debate over inflammatory cytokines and tendinosis, with some studies not detecting 
inflammatory cytokines in chronic tendinosis [127,132] and others reporting increased 
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levels of inflammatory cytokines during the three hours following mechanical loading. 
However, these levels decreased toward baseline at 12 hours post-loading [187], leading 
to speculation that inflammatory factors increase briefly following loading before 
returning to baseline.  
 Substance P (SP) is a neuropeptide that is produced by tenocytes [188] and its 
receptor, neurokinin-1 receptor (NK-1R) is found in blood vessel walls, nerves, and 
tenocytes in tendon [188]. SP has been associated with inflammation [189], angiogenesis 
[190], and cell proliferation [191,192] and the levels of SP and NK-1R have been shown 
to be increased in tendinosis. Because of the known effects of SP and NK-1R, it is 
thought that they are involved in angiogenesis and pain signaling in tendinosis [193]. 
While it is unknown whether the increased levels of SP and NK-1R are a cause or effect 
of tendinosis, a recent study has revealed that increased SP production occurs after the 
tendon undergoes mechanical loading; however, these elevated levels exist prior to 
tendinosis-like changes of the tendon. In this study, SP was noticeably elevated after one 
week of exercise, while tendinosis-like changes did not appear until at least three weeks 
of exercise [194]. This finding points to SP being a potential cause of tendinosis rather 
than an effect. In addition, Fong et al. [195] used human tenocytes in an in vitro study 
examining the effects of SP. They found an increase in type I collagen remodeling and 
increased levels of MMP-3, TIMP-1, and type III collagen in cells stimulated by SP, 
which supports the hypothesis that SP plays a role in the development or progression of 
tendinosis. While there is consensus among the current studies, the investigation of the 
role of SP in tendinosis is still in its infancy and many more studies are required before 
any definitive conclusions can be drawn.  
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1.3.2   Etiology 
 
 Understanding the etiology of tendinopathy is crucial in developing interventions 
that can be utilized prior to the onset of symptoms or tendon rupture. While little is 
known in this area of tendon research, several different factors have been identified and 
investigated. There is consensus that mechanical overuse is typically required for 
tendinopathies to exist; however, the definition of overuse is variable among individuals 
and may not be a factor in all cases, as sedentary individuals may also experience 
tendinopathy. Additionally, most agree that mechanical overuse is not the only factor 
contributing to tendinopathy, which warrants the investigation of all factors that may be 
involved, either independently or in combination. Chronic overuse injuries, including 
tendinopathies, are frequently the result of an interaction between intrinsic and extrinsic 
factors. While there is no specific combination for any tendinopathy, there are several 
common intrinsic and extrinsic factors that may have an effect on the pathophysiology of 
tendon disorders. 
 
a)  Intrinsic factors  
 
Intrinsic factors are typically a result of the genetic makeup that may predispose 
an individual to tendinopathies. For example, variants of the Col5A1 [196], tenascin C 
[197], and MMP-3 [198] genes have been associated with increased risk of Achilles 
tendon injuries. Intrinsic factors might also be expressed as a phenotype. For example, in 
the legs, misalignments and leg length discrepancy may contribute to tendinopathy. 
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Hyperpronation is a common misalignment of the foot that is the result of excessive 
calcaneal eversion and it produces a whipping or bowstring action on the Achilles tendon 
[199]. This action places eccentric load on the medial side of the Achilles tendon, which 
may predispose it to injury [200-203]. In addition, hyperpronation may contribute to 
pathology of the posterior tibialis and patellar tendons as well as the iliotibial band. 
Patellar tendinopathies may also develop in individuals with long patellar tendons, high 
riding patella, or lateral displacement of the patella [204]. Muscle weakness [205-207], 
decreased flexibility, and joint hypermobility [208-210] have also been speculated as 
factors contributing to tendinopathies; however, it is unknown if these are causes or 
consequences of musculoskeletal injuries. 
 Because females often have weaker musculoskeletal systems that are less able to 
absorb repetitive loads, gender has been implicated as a factor contributing to 
tendinopathy [204]. However, in studies of patellar and Achilles tendinopathies in 
adolescents and adults, nearly two times as many males experienced tendon pathology 
[211-213]. 
 Age is also linked to tendinopathy with both younger and older tendons being 
more likely to develop pathology. Because young tendons are small and unable to 
withstand large stresses [214], overloading the tendons may lead to tendinopathy [215]. 
Older tendons have increased stiffness and decreased ultimate strain and load, which 
decrease the tendons ability to absorb and recover from loading. These mechanical 
changes in older tendons are likely a result of a decrease in proteins required for collagen 
alignment [215] and changes in collagen cross-linking [216] and may be amplified by 
decreased vascularity [69,217]. 
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 Diseases affecting collagen, such as Ehlers-Danlos syndrome, Marfan syndrome, 
and Menke kinky hair syndrome increase the likelihood of developing tendinopathy, and 
individuals with these conditions are typically discouraged from participating in sports 
that may lead to overuse. Other diseases, including systemic lupus erythematosus [218], 
rheumatoid arthritis [219], glycogen storage disease [220], psoriasis [221], and vitamin C 
deficiency [30], may also predispose a tendon to pathology or rupture. 
 
b)  Extrinsic factors 
 
Extrinsic factors are defined as all factors acting externally on the human body 
[204]. In tendinopathies, the extrinsic factors typically include an excessive load, training 
errors, or changes in the environment. The amount of load required to become excessive 
varies among individuals and may be considered excessive in terms of training type, 
volume, intensity, or frequency. Sudden increases or changes in activity have been 
associated with pain in the patellar [222], Achilles [199], and rotator cuff tendons [223]. 
This may be due, in part, to reactive oxygen species, which are oxygen molecules with an 
unpaired electron that combine with similar nitrogen molecules and begin to induce 
cellular and matrix damage [224]. During exercise, the formation of reactive oxygen 
species is increased [204], and cell death may increase in the presence of these reactive 
species [225]. While these molecules cause damage within the tendon, regular exercise 
routines increase antioxidants, allowing the tendon to adapt to the increased levels of 
reactive species since antioxidants inhibit the formation of reactive oxygen species. 
However, sudden changes or increases in exercise may occur faster than the tendon is 
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able to adapt, leading to increased levels of these harmful molecules, and exposing the 
tendon to greater damage [224].  Therefore, slower increases or changes in training may 
help prevent the onset of tendon pathology. 
Tendons normally experience strain, or deformation, as a result of muscle forces, 
ground reaction forces, and interaction with surrounding structures. Tendons experience 
tensile (pulling), compressive (pushing), or shear (sliding) strains, with tensile being the 
most common in tendons that transmit large loads [226]. Most researchers attribute 
pathology to repeated strain that is less than the force required for rupture. This repeated 
strain damages collagen and blood vessels, decreasing the metabolic capacity of the 
tendon [204]. Because the tendon is designed to withstand large-magnitude loads, it 
normally recovers after loading by manufacturing and organizing the ECM. One 
hypothesis of tendinopathy is that the amount of strain exceeds the tendon’s capacity to 
repair [227]. 
 While tensile strains are typically the normal strain acting upon tendons, 
compressive and shear strains are frequently a result of impingement of the tendon, which 
has been reported to cause tendinopathy in the rotator cuff, Achilles, and patellar tendons. 
While impingement has been suggested as a cause for rotator cuff tendinopathy, 
contradictory viewpoints have been proposed, and thus decrease the likelihood of this 
hypothesis [228]. Similarly with the patellar tendon, it was hypothesized that the inferior 
pole of the patellar impinges on the tendon during knee flexion [229], but Schmid, et al. 
[230] found that patellar impingement is not likely a factor in patellar tendinopathy. 
However, the Achilles tendon may be impinged by the calcaneus, as the shape of the 
calcaneus affects the morphology of the Achilles insertion [231], especially during 
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dorsiflexion when the tendon bends near its attachment, resulting in the surface of the 
tendon pressing against the bone [232]. Therefore, any abnormalities in the shape of the 
calcaneus can affect the Achilles tendon during this motion. 
 Training errors have been reported to be present in 60-80% of overuse injuries 
[233] and include excessive distance, accelerated intensity progression, and hill workouts 
[204]. Monotonous training (e.g. distance running) increases the risk of tendon injuries 
and should instead be supplemented with other forms of exercise, such as biking or 
swimming. Improper technique and fatigue may also contribute to training errors, as 
frequently repeating technique errors can lead to tendon overuse and training while 
fatigued decreases the muscles’ ability to absorb repetitive stress, causing other 
structures, including the tendons, to carry excessive stresses.  
 Improper equipment also contributes to tendinopathies of several different 
tendons, depending upon the type of training. Examples include the following: improper 
footwear leading to leg malalignment; tennis rackets being too stiff or strung to tightly 
transmitting an increased force to the arm and shoulder; hand paddles in swimming 
increasing resistance on the rotator cuff; and bicycle seats being too low, increasing knee 
flexion [16]. 
 Several environmental factors may contribute to tendon pathology, including 
extreme temperatures, humidity, and altitude. High temperatures and humidity can lead to 
fatigue of the muscle-tendon units, while low temperatures may inhibit contractility, thus 
decreasing the ability of muscle-tendon units to absorb shock [204]. 
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1.3.3   Pathogenesis 
 
 While many potential causes and risk factors of tendinopathy have been 
suggested, the pathogenesis remains unclear. Several theories of pathogenesis have been 
proposed and built upon one another. As early as 1978, Burry [234] suggested that 
changes in the tendons arose from tendon lesions that had not properly healed. Later, 
Leadbetter [227] and Khan et al. [115] hypothesized that tendinosis is a result of 
increased demands on the tendon with inadequate repair and progressive cell death, 
which implicated overuse in the pathogenesis. Kibler [235] and Sorosky [236] attempted 
to explain the inadequate repair as a response to tissue overload, along with a decrease in 
the number of cells. However these theories, along with Murrell’s theory of apoptosis of 
tencoytes leading to degeneration [237-239], failed to account for the areas of 
hypercellularity within tendinopathy. Murrell’s theory did, however, suggest oxidative 
stress, areas of cartilage development, and activation of MMPs as having a role in 
tendinopathy. Along with this theory, repetitive tensile strain [180], decrease in tendon 
load (stress-shielding) [240], contractile tension overloads [241], and compression [242] 
were all suggested as stimuli for tendon inflammation or degeneration. Others have 
suggested that hypoxia, increased vascularity [243], and increases in pro-inflammatory 
neuropeptides such as SP [119,186] may be involved in the pathogenesis. While the 
proposed causes of tendinopathy are widespread, Fu, et al. [244] suggest that they all be 
combined into a three stage pathogenesis: injury, failed healing, and clinical presentation 
(Figure 1.5).  
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Figure 1.5. Failed healing theory for the pathogenesis of tendinopathy 
(Reproduced from Fu, et al. [244] with permission from BioMed Central). 
 
In this theory, injury may be a result of chemicals, such as fluoroquinolones or 
oxidative damage, previous traumatic injury that has not healed, or repetitive injury. They 
hypothesize that mechanical weakness and tendon pain are not significant during this 
stage and at this point, the tendon may be able to heal without progression. The second 
stage, failed healing, may be due to a number of factors, including mechanical overuse, 
genetic pre-disposition, hormones, or pharmacological use. Finally, this combination of 
injury and failed healing leads to the clinical presentation that may be diagnosed by a 
clinician. While this theory remains vague in the exact contributing factors, it provides a 
rational progression of the pathology that may exist in human tendons. 
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1.3.4  Prevalence 
 
 The incidence of tendinopathy is quite high in both recreational and competitive 
athletes, and, though rare, may also occur in sedentary individuals. The actual prevalence 
in each tendon is variable and highly dependent on the individual’s activity type and 
levels. For example, patellar tendinopathy has a high prevalence in athletes participating 
in sports involving jumping, with approximately 45% of elite volleyball and 32% of elite  
basketball players being diagnosed with patellar tendinopathy [245]. Achilles 
tendinopathy is the most prevalent lower extremity tendinopathy in the general 
population, with a 5.9% lifetime incidence among sedentary people [246]. This 
percentage drastically increases to 50% in elite endurance athletes [246]. Lateral 
epicondylalgia, or “tennis elbow”, is prevalent in tennis players, while medial 
epicondylalgia is prevalent in throwers and golfers. Lateral epicondylagia occurs in 1-3% 
of the general population [247] and 9-35% of all tennis players [248]. Additionally, 
rotator cuff tendinopathy is quite common in throwing sports and swimming, and may 
involve either the supraspinatus, infraspinatus, teres minor, or subscapularis tendons, with 
the supraspinatus being the most commonly injured [249]. Rotator cuff tendinopathy is 
responsible for 85% of shoulder pain incidence in patients [250] and has had increasing 
prevalence in elite swimmers from 3% in 1974 to 69% in 2010 [251]. Other common 
sites of tendon overuse include the posterior tibialis and iliotibial tract [252]. 
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1.3.5   Treatment 
 
 Many options have been proposed for the treatment of tendinopathy, but there is a 
lack of consistency in the reported efficacy. These options range from very conservative 
treatments to highly invasive procedures and include exercise, shockwave therapy, 
injections, and surgical techniques.  
 
a)   Eccentric exercise  
 
The most conservative, and arguably the most effective, treatment option is 
eccentric exercise. Eccentric exercise consists of lengthening the muscle-tendon unit and 
combines stretching and strengthening. These exercises are thought to assist tendon 
remodeling by promoting collagen fiber cross-linking within the tendon [253,254]. 
However, the actual mechanisms involved in this treatment are largely unknown. 
Eccentric loading produces pain, and as pain decreases through adaptation or 
strengthening, load is increased to re-establish the pain; therefore, it has been suggested 
that eccentric exercise leads to progressive habituation of painful stimuli [255-258]. 
Others have attributed the effect to decreased stiffness in the tendon following eccentric 
loading [259]. Although these exercises have revealed improvements in both athletic and 
sedentary patients [260-267] with no adverse effects [254], further studies are required to 
identify the adaptations of the tendons during eccentric exercises.  
Concentric exercises, which consist of shortening the muscle-tendon unit, have 
also been suggested as a treatment option for tendinopathy. However, eccentric exercises 
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have been found to be more effective than concentric exercises in improving the pain, 
dexterity, and agility in patients with tendinopathy [268-271]. 
 
b)  Extra-corporeal shockwave therapy  
 
Extra-corporeal refers to a procedure being performed outside of the body; 
therefore, this treatment option consists of shockwaves that are generated outside of the 
body. These shockwaves are either high or low energy pulses produced for short lengths 
of time. Low-energy treatment is typically administered once a week for three or four 
consecutive weeks without anesthesia, and high-energy therapy is only administered one 
time and requires local or general anesthesia [272]. These energy pulses break the sound 
barrier, creating shockwaves, which exert mechanical pressure and tension forces on the 
tissue. The waves leave bubbles, referred to as cavitation bubbles, which then collapse, 
creating secondary energy waves called microjets, which also apply mechanical force to 
the tissue. This therapy, which derived from the use of extracorporeal shockwave 
lithotripsy in the treatment of kidney stones, can be used to promote healing in both bone 
and connective tissue. As with eccentric exercise, the mechanisms are poorly understood, 
but this treatment is believed to stimulate interstitial and extracellular responses leading 
to tissue regeneration [273,274]. Similar to all tendinopathy topics, no consensus about 
shockwave therapy has been reached, with some studies reporting that shockwave 
therapy had favorable outcomes comparable to eccentric exercise [253,275,276] and 
others finding no benefit of shockwave therapy [277]. However, studies typically find 
success rates of 34-91%, with great variation in outcomes existing between different 
tendons [274]. 
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c)  Injections 
 
Numerous agents are being injected into tendons with increased frequency in 
attempts to treat tendinopathy, but the mechanisms of their use are poorly understood and 
clinical studies are very limited. Several different injections have been used, including 
corticosteroids, sclerosing agents, aprotinin, and platelet-rich plasma. The rationale and 
the efficacy of these injections vary. 
 
 Corticosteroids- Corticosteroids have been tested in several studies, with some 
researchers investigating their effect because they may reduce edema and inflammation 
of the tendon [278]. However, this contradicts the belief that tendinopathy is the result of 
degenerative changes, making the rationale behind the use of steroid injections 
questionable. Others simply include steroid injections into clinical studies because they 
are often used to treat musculoskeletal pathologies [279]. In the patellar tendon, these 
injections lead to short-term improvement of tendinopathy, but the improvement 
diminished over time, having no beneficial long-term effect [279-281], which 
corresponds with the expected result of injecting them into degenerative tendons. 
Furthermore, corticosteroids may have negative side effects, as in vitro studies have 
found that exposing tenocytes to corticosteroids has negative effects on matrix synthesis 
and cell viability [282-285]. 
 
 Sclerosing agents (Polidocanol)- Sclerosing injections involve introducing a 
chemical irritant (polidocanol) into the tendon to destroy the neovessels and nerves in an 
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attempt to alleviate the pain associated with tendinopathy. This treatment is derived from 
its use in treating varicose veins and telangiectasies (small, widened blood vessels on the 
skin) [286,287]. In tendinopathy pilot studies, two to four ultrasound-guided polidocanol 
injections led to a reduction in pain associated with tendinopathy [288,289]. In a 
subsequent study, researchers identified nerves lying closely to neovessels in 
tendinopathy biopsies and found that providing small amounts of local anesthesia into 
areas of the tendon with neovascularization temporarily relieved the pain [290]. 
Therefore, it was concluded that the neovessels and their associated nerves contribute to 
the pain associated with tendinopathy and sclerosing the areas containing these 
neurovascular bundles would decrease tendinopathy pain. Clinical assessments are 
limited, but studies have revealed that these injections do reduce the tendon pain 
[291,292]. However, Willberg, et al. [293] found that sclerosing injections were not as 
beneficial as other methods of destroying the neovascularization, such as arthroscopic 
shaving of the region of neovascularization. Also, is important to note that these 
injections may not improve the underlying pathology, and thus the degeneration leading 
to a decrease in the overall health of the tendon may continue. In addition, a risk of 
complications may exist, such as necrosis of the tendon due to a disturbance of the blood 
flow and nervous system.   
 
Aprotinin- Aprotinin is a strong inhibitor of MMPs [294-298]; therefore, injecting 
this into the tendon may decrease the excessive collagenases that likely contribute to the 
ongoing pathology in patients [299]. Injections of aprotinin have been used for the 
treatment of tendinopathy since the early 1970s [300]. More recently, others have 
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examined its efficacy and potential risks and found favorable outcomes following 
injection [279,301-304]. However, anaphylaxis and other allergic reactions are potential 
side effects that may limit the use of aprotinin [305,306], with itch and rash being quite 
common following injection [304]. Because studies examining its effect are limited, more 
research must be conducted to determine if the benefits outweigh the potential risks of 
injection [307]. 
 
 Platelet-rich plasma- Platelet-rich plasma (PRP) is prepared by separating PRP 
from platelet-poor plasma and red blood cells of autologous whole blood. PRP has been 
suggested to aid wound healing since the 1980s [308] and has recently been investigated 
in tendon healing [309-314]. The granules in PRP release many cytokines, including 
platelet-derived growth factor (PDGF), TGFβ, and VEGF [312-314], which may result in 
the production of proteins responsible for matrix synthesis and proliferation [309]. While 
initial studies using PRP to treat tendinopathies reported reduction in pain at both short-
term and long-term follow-ups [309,311-314], de Vos, et al. [315] found no improvement 
in pain or activity following PRP injections. Many of the studies reporting a positive 
outcome had very small sample sizes, which may have affected results; therefore, 
additional randomized, controlled studies with larger sample sizes are required before 
determining the effectiveness of PRP injections as a treatment option.  
 
Dry needling and autologous blood- Dry needling is performed by repeatedly 
passing a needle through the pathological region of the tendon. This technique is believed 
to disrupt the collagen fibers and stimulate bleeding and an inflammatory response. It is 
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hypothesized that this reaction of the tendon leads to strengthening of the tendon through 
the formation of granulation tissues as a result of the inflammatory response [316]. 
Autologous blood may be used in conjunction with dry needling with a rationale similar 
to the use of PRP, as the injection of autologous blood is thought to result in collagen 
regeneration and stimulation of an organized angiogenic response [315]. Studies 
examining autologous blood injections have reported decreased pain and symptoms 
resulting from lateral epicondylalgia [316,317]. Studies on the combination of dry 
needling and autologous blood are scarce, but James et al. [318] did report that the 
combination was successful in reducing the tendon thickness, the area of tendinosis, and 
the number of interstitial tears, thus showing promise as a treatment for tendinosis.  
 
d)  Surgery 
 
Surgery may be used for treatment to remove fibrotic adhesions, remove or 
debride areas of failed healing, restore vascularity, and stimulate cells to initiate protein 
synthesis and promote healing [69,272,319]. Many surgical techniques have been 
described for different tendons, but two of the primary techniques are multiple 
percutaneous longitudinal tenotomy and open tenotomy. Multiple percutaneous 
longitudinal tenotomies are performed in patients who have isolated tendinopathy with a 
well-defined lesion < 2.5 cm long and no pathology of the paratenon [320]. This 
operation may be ultrasound guided to confirm the location of the tendinopathy [320-
322], which is first identified by locating the area of maximum swelling or tenderness. 
For example, in the Achilles tendon, an incision is made at the identified location and is 
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followed by four additional incisions 2 cm medial and proximal, medial and distal, lateral 
and proximal, and lateral and distal to the site of the first incision [320]. These incisions 
are believed to improve circulation of the tendon, allowing for repair of the pathological 
region [68,323]. An open tenotomy may also be performed and requires ultrasound 
guidance to determine the proper location of the incision [320-322]. Once visible, the 
abnormal tissue is excised and the paratenon may or may not be stripped [324-330]. The 
outcome of surgery is highly variable, with a review of papers finding positive outcomes 
of surgery on patellar tendinopathy between 46% and 100% [331]. Most authors report 
favorable results following surgery in Achilles tendinopathy [114,325,332]; however, 
these results are not always observed in clinical practice [333], with some patients never 
regaining full strength and endurance [320]. Coleman et al. [331] described poor 
scientific methodology in reporting the outcome of tendons after surgery, with the highest 
success rates being described in papers with the poorest methodology. Therefore, the 
long-term outcome of surgery is still not fully identified.  
 
1.4   Models of tendinopathy  
  
In order to further the understanding of the causes, pathology, and potential 
treatments of tendinopathy, suitable animal models are required. While studies could be 
performed in humans, appropriate analyses are typically not plausible. Human tendons 
may be assessed by obtaining samples via biopsy [334], during surgery [69,134,335,336], 
or harvesting samples post-mortem [69,335]; however, the number of samples is typically 
small and appropriate control samples from normal tendons cannot be obtained since a 
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biopsy of normal tendon will likely lead to tendinopathy. Instead, many studies have been 
conducted using in vitro, ex vivo, and in vivo animal models, which allow for invasive 
studies of the tendon, its surrounding tissues, and the genes involved in the pathology. In 
vitro studies are frequently used to examine the molecular aspects of tendinopathy by 
investigating the local effects of mechanical or chemical factors upon tendon cells. 
Whole tendons may be removed post-mortem from animals or humans for ex vivo 
studies, and in vivo studies are performed to enable researchers to examine tendons in 
their natural environment, which accounts for systemic effects from the whole organism. 
 
1.4.1   In vitro models 
 
 In vitro tendon models consist of studying cellular responses to stimuli, either 
mechanical strain or xenobiotics, which are thought to be involved in the pathogenesis of 
the condition. In order to apply the mechanical stimuli, tenocytes are exposed to cyclical 
stretching and the effect of cellular deformation on the production of potential cellular 
and molecular mediators is examined [182]. This model allows researchers to explore 
cellular process, such as DNA synthesis, mitosis, gene expression, and cell differentiation 
[181,337-347]. Over time, these studies have improved as the cells are arranged and 
stretched in a way similar to the shape, alignment, and stretching that occurs in vivo 
[180], which is necessary as changing the shape of the cell may lead to different cellular 
responses [347]. By using cyclical stretching, studies have revealed molecular changes 
that are associated with inflammation, including increased levels of PGE2, COX-1 and -2, 
cPLA1, and sPLA2 [179-181].  
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 The tendon cells may also be exposed to xenobiotics such as corticosteroids and 
non-steroidal anti-inflammatory drugs (NSAIDs). When exposed to corticosteroids, the 
tendon cells resembled fibrocartilage [348]. The corticosteroids also affected matrix 
synthesis by suppressing proteoglycan production and collagen synthesis, reduced the 
overall cell number, and decreased cell viability [282-285]. NSAIDs inhibited tendon cell 
migration and proliferation, reduced GAG synthesis, and upregulated MMP expression 
[349-351]. 
 
1.4.2   Ex vivo models 
 
 Ex vivo models for tendinopathy preserve the relationship between the cells of the 
tendon and the ECM, providing a more natural environment without reducing the control 
over experimental conditions. Similar to the in vitro models, cyclical loading is 
frequently used to assess the effect of repetitive loading on the tendon. This method 
consists of applying a fluctuating force to the tendon, which has resulted in a decrease in 
ultimate force [352]. Additionally, the loading has led to increased cellular turnover and 
collagenase levels, which was interpreted as degradation [353]. However, use of this 
model does not allow for accurate detection of cell signaling due to the lack of 
vascularity and systemic signaling molecules. Also, mechanical strain differences 
between the grips and midsubstance have been found, which may be due to grip slippage 
or stress concentration effects at the grip edges [352].  
In addition to cyclical loading, creep loading has been used to mimic sustained 
loading tendon injuries. This technique involves the application of a continuous load that 
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results in continuous deformation of the tendon specimens. The results of creep loading 
are similar to those of cyclical loading, specifically with higher initial strains, which lead 
to more damage and earlier failure of the tendon [354].  
 Because tendinopathy can also occur in inactive individuals, ex vivo stress 
deprivation has been examined. The stress deprivation led to decreased tensile modulus 
and ultimate tensile stress, but had little effect on collagen [355]. Because human 
tendinopathy involves collagen changes, the use of stress deprivation models should be 
limited.  
 
1.4.3   In vivo models 
 
 Examining tendons in vivo is essential in developing a comprehensive 
understanding of the tendon. Because human studies are typically not feasible, animal 
models represent the most plausible method of conducting in vivo research of the tendon. 
Several animal species may be used for studies of tendinopathy, including non-human 
primates, horses, goats, dogs, rabbits, rats, and mice [146,356-373], but selection of the 
most appropriate animal is necessary. To do this, many factors must be taken into account 
including cost, availability, and ease of handling. For example, non-human primates 
would be ideal because they are the most similar to humans; however, their ethical 
protection, lack of availability, and high cost attenuate their use in tendon research [110]. 
Large animals, such as horses and goats, have naturally occurring tendinosis [374,375], 
but their cost and ease of handling frequently outweigh the benefit of their use. Rabbits 
may be used because of their mild-temperament and ease of handle; however, they are 
more expensive than rodents and are susceptible to life-threatening injury when 
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frightened [110]. Rats and mice are the most frequently used animals in the study of 
tendinopathy because they have short gestation periods, rapid growth rates, and short life 
spans, in addition to being low cost and having mild temperaments [110]. Once the 
appropriate animal model is chosen, in vivo analysis can be performed, typically via the 
use of chemical or mechanical tendon intervention. 
 
a)  Chemical intervention  
 
Various chemicals have been injected into animal tendons, with compounds 
having variable results. These injections include cytokines, prostaglandins, 
fluoroquinolones, and most frequently, collagenase. Stone, et al. [376] injected species-
specific cytokines into rabbit patellar tendons, which led to an initial increase in 
cellularity, followed by a return toward baseline after 16 weeks. However, these 
injections caused no matrix damage or collagen degradation, and thus all damage was 
reversible.  
Repeated injections of prostaglandins into tendons have been shown to initiate 
degeneration of the tendon in both rat Achilles tendons [377] and rabbit patellar tendons 
[378]. This was observed as fibrosis of the paratenon, adhesions, and intra-tendinous 
degeneration after five weeks of one injection per week in rat Achilles tendons [377]. A 
similar effect was observed in rabbit patellar tendons injected with PGE2 once a week for 
four weeks. These tendons had hypercellularity, loss of normal tissue architecture, focal 
areas of degeneration, and decreased collagen fibril diameter [378]. 
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 Fluoroquinolones, which have been linked to tendon rupture in humans [379-
382] have been given in oral doses to rats, with the Achilles tendons being examined for 
damage. Kato [383] found that a single administration of pefloxacin or ofloxacin caused 
inflammatory cell infiltration and disorganization of the collagen bundles of the Achilles 
tendon, with the tenocytes undergoing cell death. After replicating this study with many 
other fluoroquinolones [384-386], variability in their effects has been observed. While 
some of the compounds had no effect on the tendon, pefloxacin and fleroxacin led to 
pathological changes, including breakdown of collagen fibrils and degenerative changes 
of the tenocytes [385,386].  
 Because tendinopathy is a degenerative disorder, the breakdown of collagen is 
required in an animal model. In order to mimic this, bacterial collagenase has been 
utilized in many studies to induce degeneration of the collagen, and thus the tendon. 
Foland [387] was one of the first to inject collagenase into tendons, and did so into the 
superficial digital flexor tendon of horses. This led to lesions and increased levels of type 
III collagen. Others have used collagenase injections in the rat supraspinatus tendon, 
resulting in increased cellularity and vascularity, along with collagen disorganization 
[365]. Fu [388] examined the effect of collagenase on the patellar tendon and found 
inflammation, as well as matrix calcification at 16 weeks post-injection. Lui, et al. [389] 
performed a similar experiment but analyzed the tendons for a longer time and found that 
the tendons had healed from the collagenase injection at 32 weeks post-injection. 
Because of the drastic effect on the tendon, collagenase injections are frequently used as 
models of tendon injury [390-393]; however, because the tendon can recover from the 
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injection, their effect is acute rather than the chronic tendinopathy that humans 
experience.    
 
b)  Mechanical intervention  
 
Because tendinopathy typically occurs in athletes and active individuals [246], it 
is widely believed to be a result of overuse. In animals, fatigue loading has been used as a 
model for investigating the impact of damage accumulation on the tendon. Fatigue 
loading has been used in rat flexor digitorum longus [394] and patellar tendons [394,395] 
and consists of cyclical loading of the tendon. These studies reported changes in the 
tendon following fatigue loading, including an increase in types I, III, and V collagen 
levels, fiber deformations, microstructural damage, and variable changes in levels of 
MMP-13 and IL-1β, with higher strains causing an upregulation and lower strains 
causing a downregulation. 
Electrical muscle stimulation is frequently used to cause flexion and extension 
movements, and thus loading of the tendon [396]. This method has been used on a wide 
variety of tendons and animals, including the triceps surae muscle of rabbits [396] and 
rats [397] and the flexor digitorum profundus muscle of rabbits [149,398-400]. The 
outcomes of these studies are widespread and conflicting, with some reporting 
degeneration with increased vascularity and inflammatory cells [396], increased tearing 
of the tendon [398,399], and increased cellularity with disorganization of the collagen 
[397], while others reported no increase in vascularity or inflammatory cells [149] and no 
changes in tendinopathy-related mRNA levels [400]. Because of these contradictions, 
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electrical muscle stimulation must be further investigated before it can be considered an 
acceptable animal model for tendinopathy. 
 Treadmill running has become a commonly used method of mechanical overuse 
in attempts to develop animal models of tendinopathy. Soslowsky, et al. [401] were the 
first to demonstrate the potential for treadmill running to induce tendinopathy by running 
rats on a treadmill at 17 m/min on a 10° decline for 1 hour/day, 5 days/week for 4, 8, or 
16 weeks. Using this protocol, changes of the supraspinatus tendon became evident, 
including increased cellularity and deformation of the cell shape, which remained 
consistent from 4 to 16 weeks of treadmill running. Following this study, many other 
groups replicated the downhill running protocol and all found evidence of tendinosis in 
the supraspinatus tendon [121,402-406]. This downhill running protocol failed to affect 
the Achilles tendon [371]. However, a later study utilized enforced bipedal downhill 
treadmill running, and although this is not the natural gait of a rat, it did induce damage 
in the Achilles tendon [372]. 
 Glazebrook et al. [370] altered the supraspinatus tendinopathy protocol using 
uphill rather than downhill treadmill running and found disorganization of collagen fibers 
with increased cellularity and vascularity in the Achilles tendon. These results were 
supported by Silva, et al. [373] showing tendinopathic changes in the Achilles tendon in 
response to uphill treadmill running at 27 m/min for 4-16 weeks. More recently, however, 
Heinemeier, et al. [146] replicated the uphill running protocol while including more 
outcome measures and found no pathological changes of the Achilles tendon. She 
reported that running had a beneficial effect on the tendon by improving the mechanical 
properties of the Achilles tendon.  
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In an attempt to understand tendinopathy in sedentary individuals, disuse has been 
examined in rat Achilles tendons [407]. Rats were tail-suspended for five weeks, which 
did cause changes in the collagen; however, this study had many confounding variables, 
so no conclusive results can be deduced. 
 
1.5   The Achilles tendon 
 
 In humans, tendinosis can occur in many different tendons and can result from a 
wide variety of factors. Additionally, factors that impact one tendon may have no effect 
on another. This is evidenced by certain animal models (e.g. downhill treadmill running) 
causing tendinosis in some tendons, but not others. Therefore, each tendon must be 
individually examined. One of the most frequently pathological tendons in humans is the 
Achilles tendon, and thus examining this tendon is integral in treatment and prevention of 
injury. 
 
1.5.1   Anatomy and function 
 
 The Achilles tendon, which connects the gastrocnemius and soleus muscles to the 
calcaneus, is the strongest tendon in the human body. The two bellies (lateral and medial) 
of the gastrocnemius join the deeper soleus muscle approximately 12-15 cm from the 
insertion into the calcaneus [202,408,409]. The tendons of the two muscles fuse, forming 
one tendon, approximately 5-6 cm from the insertion. From that point, the tendon rotates 
about 90°, with the medial portion rotating posteriorly and the lateral portion rotating 
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anteriorly. The Achilles tendon inserts on the posterior surface of the calcaneus, leaving 
space between the tendon and bone, which is occupied by the retrocalcaneal bursa [231]. 
There is no synovium surrounding the Achilles tendon. Instead, the paratenon 
consists of two layers: a deep layer that lies against the epitenon and a superficial layer 
that lies against the crural fascia (deep fascia of the leg). The two layers of the paratenon 
are connected via the mesotenon, which carries blood and lymph vessels. The Achilles 
tendon can stretch to 4-5% beyond its original length without damage, but when stretched 
more than 8%, it is likely to rupture [410,411].  
 The primary function of the Achilles tendon is locomotion and understanding this 
function must be preceded by a description of the gait cycle. The gait cycle consists of 
two phases for each leg: the stance phase, during which the foot is in contact with the 
ground, and the swing phase, when the foot is off the ground and swinging forward. The 
stance phase is further divided into three phases: contact, midstance, and propulsion. The 
contact phase consists of the time the heel makes contact with the ground to the 
remainder of the foot touching the ground. Midstance beings once the entire foot is 
touching the ground, and propulsion lasts from the time the heel leaves the ground until 
the toe leaves the ground. The swing phase is also separated into phases: forward swing 
and foot descent. The first phase is the forward swing, which occurs as the foot is carried 
forward, with the knee flexed (bent) and the foot dorsiflexed (toes are brought toward the 
shin). Next is the foot descent, at which point the foot is positioned for weight bearing 
and the muscles stabilize the body to absorb the shock of heel contact [412]. Once the 
heel contacts the ground, the stance phase begins again. The gait cycle is dependent upon 
the gastrocnemius-soleus muscles that act via the Achilles tendon [202,410,411,413], 
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which controls the midstance and propulsion intervals of the stance cycle [412]. During 
normal walking, it is estimated that the muscle tension on the Achilles tendon at the end 
of the stance phase is 250% of the body weight. While running, this increases to six to 
eight times the body weight and approaches the ultimate strength of the tendon [414-
417]. Furthermore, any abnormalities in the foot positioning during the gait cycle can add 
extra forces upon the Achilles tendon. 
 
1.5.2   Etiology and pathology 
 
 Achilles tendinopathy has been identified in 30-50% of all injuries in athletes 
[204] and occurs relatively frequently in military personnel around the world [418,419]. 
This pathology may also occur in sedentary individuals [246] and can also present as 
rupture, which is common in both runners [246,420] and athletes involved in contact 
sports, such as football [421]. Achilles tendinopathy is not limited to any age group, but 
is most prevalent between ages 21 and 60 [422]. 
 Because of its poor vascularization, the Achilles tendon has limited healing 
capabilities. Conversely, the muscles are able to recover and heal quickly after training, 
which leads to an imbalance between the force the muscle can exert and the force the 
tendon can transmit. This result of excessive training is considered to be the main cause 
of Achilles tendinopathy. In addition, different activities expose the tendon to various 
stimuli, including tension, torsion, vibration, reduction of blood flow, and heat 
generation, all of which may be harmful to the tendon. Tension on the Achilles tendon 
exists during the propulsion phase of the gait cycle. Torsion and vibrations are induced 
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by a whiplash effect during the stance phase of the gait cycle and may be amplified by 
certain surfaces, such as artificial turf. All of these factors may contribute to reduced 
blood flow by constricting the blood vessels within the tendon. Finally, heat generation 
may also contribute to Achilles tendon pathology. Because of the poor vascularization, 
heat dissipation is inhibited and the tendon may overheat, leading to damage of the 
structure [412]. 
 These stimuli may have an effect on the Achilles tendon, the paratenon, or both, 
with certain areas of the tendon being more susceptible to damage than others. Pathology 
of the Achilles tendon presents similar to all tendon pathologies as previously described. 
The mid-substance of the Achilles tendon is most susceptible to damage, which appears 
as degeneration. At the insertion into the calcaneus, inflammation of the bursa may exist, 
leading to painful adherences around the tendon and bony attachment. Pathology of the 
paratenon is typically inflammation, and thus referred to as “paratenonitis”. This 
pathology is histologically identified by the proliferation of fibroblasts, infiltration of 
inflammatory cells, and fibrinous exudate [124,423,424]. In addition, deformities of the 
posterior tuberosity of the calcaneus may contribute to Achilles tendon pathology. This 
disorder is referred to as Haglund’s deformity and may be congenital or a result of 
wearing certain footwear, such as hockey skates or high-heeled shoes [423]. Haglund’s 
deformity leads to compression of the Achilles tendon and may cause a cycle of further 
enlargement of the calcaneal tuberosity which further irritates the Achilles tendon 
[202,409,423,425]. 
 A final form of Achilles tendon pathology is tearing, or rupture. Normal Achilles 
tendons are unlikely to tear, as most tears occur following degeneration. However, 
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overuse is not a necessary precursor to tearing [69,426]. Tears may be partial, with 
incomplete disruption of fibers, or total, which span the entire cross-section of the tendon. 
The causes of Achilles tendon tearing are unknown, but many have been speculated, 
including the following: direct trauma, degeneration, recurrent microtrauma, 
corticosteroids, fluoroquinolones, chronic renal failure, rheumatoid arthritis, systemic 
lupus erythematous, and diabetes mellitus [117,202,427,428]. 
 
1.5.3   Symptoms and diagnosis 
 
 The symptoms accompanying Achilles tendinosis are variable and subjective. 
Different symptoms may exist, depending on the type and extent of the pathology 
present. For example, individuals with tendinitis at the calcaneal insertion describe pain 
as they exercise, which worsens when jumping or running uphill. They also feel pain with 
palpation and have visible inflammation in the region of insertion. Patients with acute 
paratenonitis experience crepitus, or popping sounds, while moving the foot and have 
difficulty moving the ankle after resting. Chronic paratenonitis is identified with pain 
during palpation, swelling along the tendon, and pain decreasing during activity, but 
increasing after the activity has ended. Tendinosis is unique, as it is typically 
asymptomatic and only becomes painful with the presence of microscopic tearing or the 
onset of inflammation of the paratenon or retrocalcaneal bursa. Symptoms for all Achilles 
tendinopathies may become amplified by changing a training routine, changes in weather, 
or sickness such as flu or infection [199,429].  
 53 
 
 Imaging is essential in the diagnosis of Achilles tendinopathy. While radiographic 
imaging is not always ideal in diagnosis, it can be used to identify Haglund’s deformity 
and insertional tendinitis, as well as tendon calcifications and ossifications, which are 
sometimes present in tendinopathy [430-433]. Ultrasound is frequently used in the 
diagnosis of Achilles tendinopathy, as it can be used to find focal lesions within the 
tendon; however, it is inaccurate when differentiating partial ruptures from focal areas of 
tendinosis [434]. Magnetic resonance imaging (MRI) is likely the most accurate way of 
diagnosing and differentiating between the tendon pathologies. This imaging allows 
physicians to clearly view the insertion and origin along with the overall anatomy, and is 
very sensitive to pathological changes [412]. 
 
1.5.4   Treatment 
 
  Many treatment options for tendinopathy have been proposed, but few have 
undergone appropriate investigation with clinical trials [254,435]. This lack of data limits 
the knowledge required to adequately treat patients. For example, NSAIDs are frequently 
assumed to be a relevant treatment; however, this treatment would only be beneficial in 
inflammatory tendinopathies, not the more prevalent degenerative pathology [436]. 
Therefore, before making assumptions about appropriate treatments, it is important to 
fully understand the current treatment options. 
 Treatment options are divided into conservative management or surgical 
treatment, and most have insufficient evidence to be considered effective. Using braces or 
splints has been shown to be ineffective as a treatment option, as their use did not alter 
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pain, symptoms, or quality of life [437-440]. Orthotics have also been suggested, but 
there is not enough evidence to support this treatment option [440,441]. 
 Extracorporeal shock wave therapy is being used more frequently as a treatment 
option [272]. This treatment utilizes acoustic waves that may be high or low energy, 
which are believed to stimulate soft-tissue healing and inhibit pain receptors. There is 
insufficient evidence to support this therapy, as outcomes are inconsistent [275-277]. 
Rompe, et al. [276] compared extracorporeal shock wave therapy to eccentric exercise 
and found that both reduced pain but there was no difference in outcome measures 
between the two therapies. Later, they investigated the combined effect of eccentric 
exercise and extracorporeal shock wave therapy and found that the combination 
decreased pain more than eccentric exercise in isolation; however, they did not examine 
the combined effect versus the effect of extracorporeal shock wave therapy in isolation 
[275]. In contrast, Costa et al. [277] found that extracorporeal shock wave therapy 
provided no pain relief after three months of treatment.  
Dermal patches and injections have also been tested in an effort to treat Achilles 
tendinosis. Patches of glyceryl trinitrate, a prodrug of endogenous nitric oxide [442], 
have been applied to the Achilles tendon to increase levels of nitric oxide around the 
tendon. Studies have shown that inhibition of nitric oxide leads to a reduction in the 
synthesis, contraction, and amount of collagen [443] and a reduction in the CSA and 
ultimate load in tendons [444]. Therefore, it may be inferred that nitric oxide stimulates 
collagen synthesis and is necessary for maintenance of normal mechanical properties of 
the tendon. Paoloni, et al. [445] reported a reduction in pain and tenderness after 12 and 
24 weeks of use of the glyceryl trinitrate patch, but the patch also caused side effects 
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including rash and headache. Several injection therapies have been tested, including 
corticosteroids, sclerosing therapy, aprotinin, and platelet-rich plasma [200,281,440,446-
449]. Studies on these injections are very limited and none of the injections have been 
definitively supported or refuted in the treatment of Achilles tendinopathy. 
While the previous options lack evidence or support, eccentric exercise has been 
shown to be successful [267,275,441,450]. This exercise provides a strong, controlled, 
mechanical force to the tendon by lengthening the muscle, which is generally achieved by 
dropping the heel over a step. As the patient adapts to the exercise, the load is gradually 
increased by adding weight or using weighted gym equipment. This therapy has been 
shown to decrease pain and is associated with very little risk if progression is gradual and 
monitored by a health professional [440]. 
Contrary to conservative management of tendinopathy, surgical treatment may be 
used to remove adhesions, remove or debride areas of failed healing, restore vascularity, 
and potentially stimulate cells to resume their normal activities [272]. Several surgical 
techniques are used, including removing hypertrophic regions of the paratenon [11,325-
330], removal of abnormal tissue through a central longitudinal tenotomy [324-330], or 
multiple percutaneous longitudinal incisions in the area of tendinosis [320]. Surgery 
requires a long recovery and gradual return to activity, and thus is typically used as a last 
resort if other options failed at alleviating the symptoms.  
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1.6   Summary and aims 
 
1.6.1   Tendinopathy summary 
 
Tendinopathy is a common pathology that may exist in both active and sedentary 
individuals. While it was once thought to be a result of inflammation of the tendon, or 
“tendinitis”, many studies have revealed that tendinopathies are actually due to tendon 
degeneration and should be referred to as “tendinosis”. This condition is characterized by 
activity-related pain, focal tendon tenderness, intratendinous imaging changes, and 
typically results in changes in the histological, mechanical, and molecular properties of 
the tendon. Many tendons are susceptible to tendinosis and each is likely affected by 
different factors, either extrinsic, intrinsic, or a combination of both. Although the 
condition is quite common, knowledge concerning the pathology is very limited. This 
limited knowledge is primarily a result of tendinosis being difficult to study in humans; 
therefore, animal models that mimic the human condition are required. The variation in 
etiology among tendons requires that models be developed for each tendon. Models have 
been established for some tendons, such as the supraspinatus; however, a consistently 
reliable model of Achilles tendinosis has yet to be established. 
 
1.6.2   Dissertation overview 
 
The purpose of this dissertation is to investigate the effects of an extrinsic factor, 
an intrinsic factor, and a combination of both in an attempt to develop an acceptable 
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animal model of Achilles tendinosis that mimics the human condition. To do this, an 
extrinsic factor, uphill treadmill running, and/or an intrinsic factor, intratendinous 
collagenase injection, was introduced to rodents. This research expands upon previous 
research in several ways. First, greater incline and running speeds were used. Second, 
these studies investigate the combination of intrinsic and extrinsic factors, which has only 
been reported once in the literature [391]. Finally, rats selectively bred for high capacity 
running (HCR) were used.  
 
a)   High capacity running rats 
 
HCR rats are derived from a founder population of genetically heterogeneous 
N:NIH rats that have been artificially selected for intrinsic aerobic endurance running 
capacity. Prior to endurance testing, rats were acclimated to the treadmill by gradually 
increasing the running speeds from 10 m/min for 5 minutes on a 15° incline to 15 m/min 
for the same duration and at the same slope. The treadmills were equipped with an 
electric shock grid that delivered a mild shock when the rat rested at the base of the 
treadmill. This assisted the acclimation by encouraging rats to run rather than be shocked 
and also played a role in the determination of aerobic capacity. 
 During the second week, the rats were evaluated for maximal running endurance 
capacity for five consecutive days. To perform this test, rats began running on a slope of 
15° at 10 m/min. The speed of the treadmill was increased by 1 m/min every 2 minutes 
until the rat was exhausted. Exhaustion was defined as the third time the rat remained on 
the shock grid for 2 seconds. 
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 After completing the running trials, the 13 highest and 13 lowest capacity rats of 
each gender were randomly bred. The offspring underwent the same treadmill 
acclimation and running capacity trials and were bred in the same manner. By the sixth 
generation, the high capacity rats ran 839 ± 21 m before exhaustion, while the low 
capacity rats ran 310 ± 8 m. As a point of reference, the founder population ran 355 ± 11 
m before exhaustion [451]. This selective breeding has continued for many generations 
and the difference between high- and low-capacity endurance continues to grow (Figure 
1.6).  
 
 
Figure 1.6. Progression of difference between high and low capacity runner 
rats in running distance during untrained phenotype endurance testing. 
(Reproduced with permission from the laboratory of Jun Li, University of 
Michigan). 
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HCR rats were selected for two of the studies included in this dissertation. 
Because of their increased aerobic capacity, they are able to run at greater speeds for 
longer durations than standard rats. This is essential in studies using treadmill running in 
an attempt to stimulate mechanical overuse. In the wild, rats naturally locomote 
approximately 8 km/night [452]; therefore, using rats that are able to run longer distances 
may allow mandatory treadmill running that approaches the distances run in the wild, and 
thus are more likely to result in mechanical overuse affecting the Achilles tendon.  
 
b)  Extrinsic factor 
  
For the studies of this dissertation, mechanical overuse via uphill treadmill 
running is used as the extrinsic factor in attempts to create an animal model of Achilles 
tendinosis. Although electrical muscle stimulation has been suggested as a mechanical 
overuse model, studies using this method to examine the Achilles tendon are limited. In 
contrast, numerous investigators have attempted to use treadmill running as a means of 
mechanically overloading the rodent Achilles tendon [146,369-373]. Some success has 
been reported in terms of inducing histopathological and mechanical changes consistent 
with human Achilles tendinosis [370,372]; however, these have not been replicated and, 
more recently, have been contradicted, with Heinemeier, et al [146] reporting that uphill 
treadmill running is beneficial to the Achilles tendon. Therefore, treadmill running was 
used for this dissertation in attempt to further investigate these studies. Specifically, 
uphill treadmill running was used instead of downhill, as uphill running has been reported 
as more successful in inducing changes to the Achilles tendon.  
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c)  Intrinsic factor 
 
 Collagenase injection directly into the Achilles tendon was chosen as the intrinsic 
factor for the studies included in this dissertation. Collagenase catalyzes the hydrolysis of 
collagen and has elevated expression in human tendinosis [370]. Intratendinous injection 
of collagenase into the Achilles tendon results in an acute and intense inflammatory 
reaction (tendinitis) followed by progressive tendon healing [121,390-392]. Therefore, 
collagenase injection was used to create an initial injury that could be intensified by 
repetitive use.  
 
1.6.3   Aims 
 
The overall aim of this dissertation was to investigate the individual and 
combined effects of treadmill running (extrinsic factor) and collagenase injection 
(intrinsic factor) in creating pathology within the rat Achilles tendon consistent with 
Achilles tendinosis in humans. Specifically, we assessed the effect of uphill treadmill 
running and collagenase injection on the histological, mechanical, and molecular 
properties in rats. 
The general aims of this dissertation are to investigate: 
1. The effect of an extrinsic factor (uphill treadmill running) on the rodent 
Achilles tendon; 
2. The effect of an intrinsic factor (collagenase injection) on the rodent Achilles 
tendon; and 
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3. The combined effect of an extrinsic (uphill treadmill running) and intrinsic 
(collagenase injection) factor on the rodent Achilles tendon. 
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CHAPTER TWO: THE EFFECT OF UPHILL RUNNING ON THE HISTOLOGICAL 
APPEARANCE OF THE ACHILLES TENDON IN HIGH CAPACITY RUNNING 
RATS 
 
2.1   Introduction 
 
Despite consistent identification of the pathology underlying Achilles 
tendinopathy, little is known about the pathological process/es taking place within the 
tendon. This limited knowledge has restricted treatment options, with clinical 
management presently being more of an art than a science. In order to address this void, a 
suitable animal model of Achilles tendinosis is required. As knowledge regarding human 
Achilles tendinosis is currently centered around its histopathological features, a suitable 
animal model is one in which the histopathological features of the injured animal 
Achilles tendon replicate those observed in the human condition.  
Treadmill running represents a potential means of repetitively loading tendons in 
rats to induce histopathological changes. Although established for the generation of 
supraspinatus tendinosis [401], treadmill running has had variable success in developing 
tendinosis-like changes in rat Achilles tendons [146,369-373]. Soslowsky and colleagues 
[371] used the same downhill (10º decline) treadmill running program (17 m/min, 1 hr/d, 
5 d/wk for up to 16 weeks) as they used to induce supraspinatus tendinosis in an 
unsuccessful attempt to induce mechanical and geometric changes within the rat Achilles 
tendon. A possible explanation for the lack of an effect may be that downhill running in 
quadrupeds results in a forward shift of the center of mass [453] resulting in increased 
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forelimb loading (and elevated subacromial compression) combined with a relative 
decrease in hindlimb loading. 
Glazebrook et al. [370] replicated the same running program as Soslowsky and 
colleagues [371], but furthered the work by running rats uphill (10º incline) rather than 
downhill for up to 12 weeks. Uphill running requires the calf muscles (and other 
antigravity muscles) to contract concentrically to raise the center of mass with each step. 
The net result may be increased Achilles tendon loading as the increased muscle forces 
are transmitted to the skeleton. Glazebrook et al. [370] showed uphill running resulted in 
histological changes consistent with human Achilles tendinosis, including a reduction in 
collagen organization and an increase in tenocyte number [370]. However, the latter 
observations were not replicated by Heinemeier et al. [146] who completed a 
comprehensive study using the same uphill running program, but with the modification of 
increased running speed (20 m/min). 
 The aim of this study was to build upon these previous studies and investigate 
whether uphill treadmill running at a higher incline (15º) and speed (up to 30 m/min) 
creates histopathological changes within the rat Achilles tendon consistent with Achilles 
tendinosis in humans. Specifically, we assessed the effect of uphill treadmill running on 
Achilles tendon collagen arrangement, tenocyte morphology, cellularity, and 
vascularization in rats selectively bred for high-capacity running. 
 
 
 
 
 64 
 
2.2   Methods 
 
2.2.1   Animals 
 
Twenty-six male HCR rats (age = 24.8 ± 3.2 weeks; weight = 374.0 ± 30.3 g) 
were acquired from the University of Michigan (Ann Arbor, MI) and acclimated for 2 
weeks. HCR rats have been artificially selected for aerobic capacity from a founder 
population of genetically heterogeneous N:NIH rats [451]. Animals in the current study 
were from the 26
th
 generation of HCR rats, with this strain of rat being used due to their 
known ability to run long distances. Rats in this study ran an average distance of 1.7 ± 0.1 
km within 64.8 ± 1.1 min on a treadmill when phenotyped as untrained, young adults.  
All animals were maintained under standard conditions and provided ad libitum 
access to food and water. All procedures were performed following a priori approval 
from the Indiana University Institutional Animal Care and Use Committee. 
 
2.2.2   Treadmill running 
 
 Animals were randomly divided into two groups: cage control (n = 11) and 
running (n = 15). Rats in the cage control group maintained normal cage activity 
throughout the duration of the study. Rats in the running group ran 5 days/week for 9 
weeks on a treadmill at a 15° incline. Rats were acclimated to the treadmill starting with 
5 minutes at 10 m/min. The duration and speed of running were gradually increased 
throughout weeks 1 and 2 until the rats were running for 60 minutes at 25 m/min (Table 
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2.1). The duration was kept constant for the remainder of the study while speed was 
progressively increased up to 30 m/min by the final week of running. Treadmills were 
equipped with an electric shock grid set to 10 Hz. If rats remained on the shock grid for 
more than three seconds, they were manually prodded back onto the treadmill or removed 
from the shock grid and placed onto the treadmill. If this occurred more than five times, 
the rat was removed from the treadmill and allowed to rest until the running session the 
following day. 
 
Table 2.1. Running protocol used for the running group of rats. 
 
    
Duration 
(min) 
Speed* 
(m/min) 
Week 1 Day 1 5 10 
 
Day 2 5 10 
 
Day 3 5 10-15 
 
Day 4 5 10-25 
 
Day 5 30 15-25 
Week 2 Day 6 45 15-25 
 
Day 7 50 15-25 
 
Day 8 55 15-25 
 
Day 9 60 15-25 
 
Day 10 60 15-25 
Week 3 
 
60 15-25 
Week 4 
 
60 20-25 
Week 5 
 
60 20-25 
Week 6 
 
60 20-25 
Week 7 
 
60 20-27.5 
Week 8 
 
60 20-27.5 
Week 9   60 20-30 
    *Hyphenated values in the speed column represent the gradual increase in speed at the 
beginning of each running session. Running began at the lower speed and was increased 
by 1 m/min each minute until the higher speed was achieved. Rats ran at this higher 
speed for the remainder of the duration of that running session. 
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2.2.3   Histology 
  
Animals were euthanized after 9 weeks of the running regimen and one of their 
Achilles tendons was harvested and fixed in 10% neutral buffered formalin for 48 hours 
before being transferred to 70% ethanol. Tendons were embedded in paraffin and 6 µm 
thick midsubstance sagittal sections were cut using a microtome and stained with 
hematoxylin and eosin.  
Prior to staining, acid alcohol was prepared by combining 2,000 mL 70% ethanol 
with 10 mL hydrochloric acid, and ammonia water was prepared by combining 2,000 mL 
distilled water with 6 mL 0.3% ammonium hydroxide. Hematoxylin (#01560 - Harris’ 
Hematoxylin) and Eosin (#01600 - Eosin) were obtained from Surgipath (Leica 
Biosystems; Nussloch, Germany). A Shandon Linistain GLX (ThermoFisher Scientific; 
Waltham, MA) was used for hematoxylin and eosin staining using the following 
protocol: First, sections were soaked in three baths of xylene for five minutes each. Next, 
they were dehydrated in 100% ethanol twice for three minutes each, 95% ethanol for 
three minutes, 70% ethanol for three minutes, and then placed into water for one minute. 
Sections then went through a series of eight hematoxylin stains, spending 30 seconds in 
each stain bath for a total of four minutes in hematoxylin. They were dipped into water 
for 30 seconds, and then quickly dipped into acid alcohol four times. Sections were 
placed into water for 30 seconds, ammonia water for 30 seconds, then water for 30 
seconds. Next, the slides were dipped into two eosin baths for 30 seconds each, totaling 
one minute in eosin. Sections then went through another round of dehydration, spending 
30 seconds in 70% ethanol, one minute in 95 % ethanol, and two periods of three minutes 
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in 100% ethanol. Finally, sections were placed into xylene for three minutes. Following 
staining, slides were dipped into fresh xylene for three minutes and cover slipped with 
eukitt, a xylene-based mounting media. Sections were then viewed on a Zeiss Axiophot 
light microscope and tendon damage assessed using a modified Bonar histopathology 
scale [120,121,454]. 
The most pathological region of the tendon was determined based upon collagen 
arrangement under polarized light. In this region, tendons were graded for collagen 
arrangement (one field of view at 100x), tenocyte morphology (four fields of view at 
200x), cellularity (one field of view at 100x), and vascularity (up to 10 fields of view at 
400x). A greater number of fields were viewed for characteristics requiring assessment at 
higher magnification in an effort to grade a similar total area of tissue for each outcome. 
The characteristics were graded between 0 (normal) and 3 (maximum pathology) (Table 
2.2) [122]. The sum of all 4 categories gave a completely normal tendon a score of 0 and 
a tendon with maximum damage a score of 12. Samples were randomized and graded by 
two independent blind examiners. Discrepancies in scoring were resolved by a 
discussion, with a third examiner being consulted when consensus could not be reached. 
 
2.2.4   Statistics 
 
Statistical analyses were performed using the Statistical Package for Social 
Sciences (SPSS 19.0; IBM) software, with tests being two-tailed with a level of 
significance set at 0.05. Kolmogrov-Smirnov and Levene tests were used to test for the 
presence of a normal distribution and homogeneity of variance, respectively. Mann-
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Whitney U tests were used to compare histopathological scores between groups because 
the data did not meet the assumptions required for parametric statistics. Kappa statistics 
were calculated to measure the inter-rater agreement.  
 
 
Table 2.2. Semiquantitative scale used to grade tendons. 
 
*If >20% of nuclei in the field of view receive a higher score, the tendon receives the higher score (ie- if 
75% of the field of view is grade 1 and 25% is grade 2, the tendon will receive a 2 for this category). 
 
2.3   Results  
 
 Animals in the running group ran on the treadmill an average of 51.2 ± 7.5 km 
during the study (Figure 2.1 and Table 2.3). Tendons from the cage control and running 
groups were similar on gross histological appearance (Figure 2.2). Kappa statistics 
ranged from 0.60 to 0.78 for each assessed characteristic (Table 2.4). There were no 
group differences within any of the individual histopathological categories assessed (all P 
> 0.16) or for total histopathological score (P = 0.13) (Table 2.4).  
Characteristic Grade 0 Grade 1 Grade 2 Grade 3 
 
Collagen 
arrangement 
 
 Tightly cohesive, well 
demarcated bundles 
 Smooth, dense 
homogeneous polarization 
pattern 
 Normal crimping 
 Separation of individual 
fiber bundles 
 Demarcated bundles 
 Non-homogeneous 
polarization 
 Separation of fibers 
 Loss of demarcation of 
bundles 
 Expansion of tissue 
 Clear loss of normal 
polarization pattern 
 Marked separation of fiber 
bundles 
 Complete loss of 
architecture 
 
Tenocyte  
Morphology* 
 
 Elongated, spindle-shaped 
nuclei 
 No obvious cytoplasm 
 Ovoid to round nuclei 
 No conspicuous cytoplasm 
 
 Round and slightly  
enlarged nuclei 
 Small amount of visible 
cytoplasm 
 
 Large, round nuclei 
 Abundant cytoplasm 
 Formation of lacunae 
 
Cellularity 
 
 Many discrete cells   Hypercellular ( > 30 
nuclei/field of view) 
 Cells in runs 
 
 Areas of hypo ( < 20 
nuclei/field of view) and 
hypercellularity 
 Mostly acellular 
 
Vascularity  Inconspicuous blood  
vessels between fiber 
bundles 
 
 < 2 clusters of vessels 
 
 2-3 clusters of vessels 
 
 > 3 clusters of vessels or 
pathological avascularity 
 
*If >20% of nuclei in the field of view receive a higher score, then the tendon receives the higher score (ie- if 75% of the field of view is grade 1 
and 25% is grade 2, the tendon will receive a 2 for this category). 
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Figure 2.1. Cumulative distance ran on the treadmill by rats in the run 
group. Error bars represent standard deviation. 
 
Table 2.3. Weekly running distances by rats in the run group. Distances are presented 
in km and maximum represents the maximum possible distance for that week. 
           Rat Week Total 
  1 2 3 4 5 6 7 8 9   
1 0.95 6.43 6.73 5.19 6.27 5.32 6.47 7.27 6.59 51.19 
2 0.84 5.20 7.00 7.03 5.88 4.47 5.04 3.73 7.98 47.16 
3 0.68 5.37 6.89 6.88 6.09 4.33 7.89 7.54 4.68 50.35 
4 0.92 5.40 7.15 6.83 7.30 6.12 7.62 7.98 4.88 54.19 
5 0.93 6.48 7.23 7.43 7.43 7.43 7.62 6.80 4.04 55.36 
6 0.73 6.44 7.14 6.76 6.83 7.25 6.99 7.40 7.83 57.36 
7 0.95 6.48 7.23 7.43 7.43 7.43 8.09 7.98 8.02 61.02 
8 0.95 6.48 7.23 7.43 7.43 7.43 8.09 8.09 8.70 61.80 
9 0.95 5.85 4.99 6.82 3.45 3.49 1.57 3.03 3.15 33.27 
10 0.95 5.65 6.90 6.95 6.92 6.55 4.85 2.48 1.50 42.74 
11 0.95 6.48 7.23 7.43 7.43 7.18 3.42 1.07 2.80 43.96 
12 0.00 4.11 7.10 7.43 7.43 7.43 4.27 3.75 5.24 46.74 
13 0.92 6.35 7.23 7.43 7.43 7.43 6.47 5.40 4.90 53.54 
14 0.95 6.48 6.35 7.03 7.07 7.30 6.19 6.40 5.85 53.61 
15 0.91 5.85 6.05 7.13 7.13 7.03 8.04 7.02 7.00 56.15 
Maximum 0.95 6.48 7.23 7.43 7.43 7.43 8.09 8.09 8.73 61.86 
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Figure 2.2. Representative photomicrographs of the Achilles tendon. A) run 
group and B) control group tendons. Note the uniform appearance of tightly 
packed, well-aligned collagen fibrils with interspersed, spindle-shaped tenocytes 
aligned parallel to the fibrils in the tendons from both groups (Stain = 
Hematoxylin & Eosin). 
 
 
Table 2.4. Differences in individual histopathological categories and total 
histopathological score in Achilles tendons. Differences are shown as mean ± SD. 
 
Histopathological characteristic Cage control Run Kappa statistic 
Collagen arrangement 1.91 ± 0.83 1.70 ± 0.70 0.78 
Tenocyte morphology 0.91 ± 0.70 0.78 ± 0.60 0.60 
Cellularity 1.37 ± 0.50 1.00 ± 0.60 0.78 
Vascularity 0.91 ± 0.83 0.78 ± 0.95 0.78 
Total score 5.09 ± 1.58 4.26 ± 1.68 - 
 
 
2.4   Discussion  
 
Histopathological evaluation of the tendon specimens failed to differentiate 
between the control rats and the running rats. These data suggest that uphill treadmill 
running in rodents may not be a suitable animal model for the study of human Achilles 
tendinosis. Achilles tendinosis in humans is characterized by tissue degeneration with a 
failed reparative response [69,115,455]. These changes are identified histologically as 
collagen fiber disorganization, hypercellularity with atypical tenocyte proliferation and 
BA
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morphology, and neovascularization [69,117,456]. We did not observe changes in these 
or other individual histopathological categories for human Achilles tendinosis in the 
current animal study.  
Uphill treadmill running in rats has had variable success in producing tendinosis-
like changes in the Achilles tendon, with some investigators reporting preliminary 
tendinosis-like changes [369,370,373] whereas others reported no evident pathology 
[146]. The current study used a running program (15° incline with speeds of up to 30 
m/min) seemingly more intense than these previous studies, but was unable to find 
histopathological evidence of Achilles tendinosis. These findings support those of 
Heinemeier et al. [146] who found that an uphill running program had no effect on the 
histological appearance and actually improved some mechanical properties of the rat 
Achilles tendon. These cumulative data suggest that uphill treadmill running in isolation 
in rats is unable to induce the same histopathological changes as observed in human 
Achilles tendinosis. Ng et al. [372] recently described a unique bipedal running model 
wherein rats ran at 17 m/min on a treadmill at a 20° decline, but with the animals in an 
upright posture. This model resulted in a decrease in Achilles tendon mechanical 
properties as well as histological changes associated with human Achilles tendinosis; 
however, the model has yet to be replicated. 
One of the strengths of this study was the age of the animals which were older 
than those used in previous studies. The use of older animals may facilitate the 
development of tendon pathology if it occurs. Another strength of this study was the use 
of animals selectively bred for aerobic capacity. The use of HCR rats enabled us to run 
the animals at a greater incline and at a faster pace than in previous studies, with the 
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intent that these parameters would potentiate the generation of Achilles tendon 
degeneration. However, this study strength may also be a weakness as the selective 
breeding of the animals for aerobic capacity may also have led to the development of a 
tendon phenotype that enhanced tendon resistance to degeneration. Similarly, this study 
was limited by its relatively small number of animals and limited outcome measures. It is 
not likely that increasing the sample size would have altered the study conclusions as the 
total histopathological score in treadmill ran rats in the current study were actually about 
25% better than in cage controls. A final limitation of the current study was the relatively 
prolonged treadmill acclimation period which lasted 2 weeks and subsequent relatively 
short period (7 weeks) of running at full speed and duration. These factors may have 
potentiated tendon adaptation to running and/or limited the ability to produce detectable 
pathology. 
In summary, we were unable to identify histopathological changes in the Achilles 
tendon of rats that ran uphill on a treadmill. These cumulative data suggest that uphill 
running in isolation in rats is unable to induce the same histopathological changes as 
observed in human Achilles tendinosis.  
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CHAPTER THREE: THE EFFECTS OF UPHILL RUNNING AND COLLAGENASE 
INJECTION ON THE ACHILLES TENDON IN HIGH CAPACITY RUNNING RATS 
 
3.1   Introduction 
 
Recent decades have witnessed significant advances in the understanding of 
tendon pathologies. It is now generally accepted that the predominant pathology 
underlying chronic tendon injuries is degeneration (tendinosis), as opposed to the 
historically assumed inflammation (tendinitis) [69,111,457]. Tendinosis is characterized 
histologically by a loss of collagen fibril alignment coupled with increased collagenase 
activity, atypical fibroblast proliferation and neovascularization. The ultimate 
consequence is mechanical weakening and a subsequent propensity for the afflicted 
tendon to rupture. Various animal models have been developed to advance our 
understanding of tendinosis [458]. These include models for supraspinatus [459], elbow 
common extensor origin [460] and patellar tendinosis [461], with each model replicating 
certain histopathological and mechanical features of human tendinosis. To date, no 
accepted small animal model exists for Achilles tendinosis.  
 Numerous attempts have been made to develop an animal model of Achilles 
tendinosis. The most common approaches have been to inject the tendon with collagenase 
or mechanically overload the tendon via treadmill running. Collagenase catalyzes the 
hydrolysis of collagen and has elevated expression in human tendinosis [462]. However, 
intratendinous injection of collagenase into the Achilles tendon results in an acute and 
intense inflammatory reaction (tendinitis) followed by progressive tendon healing [390-
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393]. This does not replicate the degenerative pathology (tendinosis) observed in the 
human Achilles tendon. Some success at replicating human Achilles tendinosis has been 
reported with mechanical overloading of rat Achilles tendons via forced treadmill 
running [370,372]; however, these studies have yet to be replicated and more recently it 
was reported that a similar treadmill running protocol was actually beneficial to the 
tendon [146]. Furthermore, the first study of this dissertation found no effect of running 
on the Achilles tendon. 
A potential reason for the variable success of previous efforts to develop an 
animal model of Achilles tendinosis may be that only part of the etiological cause was 
introduced. The development of Achilles tendinosis is multifactorial and thought to result 
from a combination of extrinsic and intrinsic factors. Extrinsic factors (such as 
mechanical overuse) are most commonly indicted, but the development of Achilles 
tendinosis in some individuals while others with equivalent loading are spared indicates 
intrinsic factors also play a role. With this multifactorial etiology in mind, it was our 
hypothesis that in order to develop an animal model of Achilles tendinosis a combination 
of an intrinsic and extrinsic factor for Achilles tendinosis needs to be introduced. While 
uphill running in isolation failed to create a pathology in the Achilles tendon in the first 
study of this dissertation, this method of overuse was used in the current study with a 
different rationale. In the previous study, no initial injury existed, whereas in this study, 
an intial injury is introduced and treadmill running represents the failed healing stage in 
the pathogenesis of tendinopathy. The intrinsic factor (intratendinous collagenase 
injection) will generate matrix changes, while the extrinisic factor (mechanical overuse 
via treadmill running) will restrict repair of the initial matrix changes and cause 
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progression to a degenerative lesion. This dual method has previously been used to 
advance the pathology in a rat model of rotator cuff disease [365,463].  
 The aim of the current study was to investigate the individual and combined 
effects of collagenase injection (intrinsic factor) and treadmill running (extrinsic factor) 
in creating pathology within the rat Achilles tendon consistent with Achilles tendinosis in 
humans. Specifically, we assessed the effect of collagenase injection and uphill treadmill 
running on the histological, mechanical, and molecular properties in rats selectively bred 
for high-capacity running. 
 
3.2  Methods 
 
3.2.1  Animals 
 
Eighty-eight HCR rats (36 female and 52 male; age = 35.5 ± 7.9 wk) were 
obtained from the University of Michigan (Ann Arbor, MI) and acclimated for a 
minimum of 2 weeks. Animals were from the 26
th
, 27
th
 and 28
th
 generations of HCR rats, 
and ran an average distance of 1.8 ± 0.3 km within 68.1 ± 7.5 min on a treadmill when 
phenotyped as untrained, young adults. Animals for each outcome measure were age-, 
gender- and generation-matched, and were maintained under standard conditions with ad 
libitum access to food and water. All procedures were performed following approval 
from the Indiana University Institutional Animal Care and Use Committee. 
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3.2.2  Intrinsic factor 
 
All animals had their right Achilles tendon injected with collagenase at baseline to 
induce preliminary tendon changes (Figure 3.1). Collagenase was prepared by dissolving 
100 mg of bacterial collagenase type I (Sigma-Aldrich, Inc., St. Louis, MO) in 10 mL of 
phosphate buffered saline and sterile filtering through a 0.22 µm filter. With the animal 
under inhalation anesthesia, 30 µL (0.3 mg) of collagenase was injected percutaneously 
into the right Achilles tendon 2 mm proximal to the calcaneus using a 50 µL syringe 
equipped with a 22G needle (Hamilton Company, Reno, NV). A one-time intratendinous 
dose of 0.3 mg of collagenase was chosen based on previous work showing this dose 
consistently induces matrix changes, including an initial acute and intense inflammatory 
reaction coupled with collagen disruption followed by progressive tendon healing [390-
393]. Left Achilles tendons were not injected and served as non-injected controls. All 
animals were returned to their home cage upon recovery from anesthesia.  
 
 Figure 3.1. Collagenase injection into the Achilles tendon. 
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3.2.3  Extrinsic factor 
 
Animals were randomly divided into treadmill running and cage control groups at 
nine days post-collagenase injection. A delay between the introduction of the intrinsic 
and extrinsic factors was permitted to allow the initial collagenase-induced inflammation 
to subside leaving a mechanically-compromised tendon with matrix changes. The 
treadmill running group ran on a treadmill at a 15° incline, 5 days/week for either 4 or 10 
weeks (Table 3.1). In animals that ran for 10 weeks, speed and duration were gradually 
increased during the initial 2 weeks until they were running at 20 m/min for the 
maximum duration of 60 minutes, as previously described [122]. Thereafter, speed was 
increased every second week to a maximum of 30 m/min by the 10
th
 week of running. 
Animals in the 4 week running group were exposed to a more vigorous running regimen 
in order to potentiate tendon damage in a shorter period. These rats ran for 60 minutes at 
15 m/min by the end of the first week. Thereafter, speed was increased every week to a 
maximum of 25 m/min by the 4
th
 week of running. Cage control animals were restricted 
to cage activities for either 4 or 10 weeks.  
 
3.2.4  Histopathological analysis 
 
Achilles tendons from 24 male rats (4 wk: n = 5 treadmill running and 4 cage 
control; 10 wk: n = 8 treadmill running and 7 cage control) were harvested and fixed in 
10% neutral buffered formalin for 48 hours before being transferred to 70% ethanol.  
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Table 3.1. Running protocol used for the running group of rats.  
    4 week   10 week 
    
Duration 
(min) 
Speed 
(m/min)   
Duration 
(min) 
Speed 
(m/min) 
Week 1 Day 1 15 15 
 
5 10 
 
Day 2 20 15 
 
5 10 
 
Day 3 45 15 
 
5 10-14 
 
Day 4 60 15 
 
5 10-18 
 
Day 5 60 15 
 
30 15-25 
Week 2 Day 6 60 15-20 
 
45 15-20 
 
Day 7 60 15-20 
 
50 15-20 
 
Day 8 60 15-20 
 
55 15-20 
 
Day 9 60 15-20 
 
60 15-20 
 
Day 10 60 15-20 
 
60 15-20 
Week 3 
 
60 15-25 
 
60 15-25 
Week 4 
 
60 20-25 
 
60 15-25 
Week 5 
 
- - 
 
60 20-25 
Week 6 
 
- - 
 
60 20-25 
Week 7 
 
- - 
 
60 20-27.5 
Week 8 
 
- - 
 
60 20-27.5 
Week 9 
 
- - 
 
60 20-30 
Week 10  - -  60 20-30 
        
Tendons were embedded into paraffin and thin (6 µm) midsubstance sagittal 
sections were cut using a microtome and stained with hematoxylin and eosin. Sections 
were viewed on a Zeiss Axiophot light microscope and assessed for damage using a 
modified Bonar histopathology scale [120,121,456]. The most pathological region of the 
tendon was determined based upon collagen arrangement using polarized light. In this 
region, tendons were graded for collagen arrangement (one field of view at 100x), 
tenocyte morphology (four fields of view at 200x), cellularity (one field of view at 100x), 
and vascularity (up to 10 fields of view at 400x). A greater number of fields were viewed 
for characteristics requiring assessment at higher magnification in an effort to grade a 
similar total area of tissue for each outcome. The characteristics were graded between 0 
(normal) and 3 (maximum pathology). The sum of the four categories gave a completely 
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normal tendon a score of 0 and a tendon with maximum damage a score of 12. Samples 
were randomized and graded by two independent blind examiners. Discrepancies in 
scoring were resolved by discussion, with a third examiner being consulted to assist in 
achieving consensus. 
 
3.2.5  Mechanical testing 
 
Whole hindlimbs were removed from 28 male rats (4 wk: n = 8 treadmill running 
and 6 cage control; 10 wk: n = 8 treadmill running and 6 cage control) and stored at          
-20°C. Hindlimbs were thawed at room temperature on the day of testing with all testing 
being performed at a constant room temperature of 22˚C. Muscle-Achilles tendon-bone 
units were harvested by dissecting the calcaneus and transecting the mid-belly of the 
gastrocnemius-soleus muscle complex. Muscle fibers were stripped away to leave the 
gastrocnemius-soleus epimysium and the paratenon was removed from around the 
Achilles tendon. The muscle-Achilles tendon-bone units were fixed to an electromagnetic 
mechanical actuator (Bose
®
 ElectroForce
®
 3200 series; Bose Corporation, Minnetonka, 
MN), with the calcaneus embedded in a fixture containing a low-melting point alloy 
(Bismuth Alloy; Small Parts, Inc., Miami Lakes, FL) and gastrocnemius-soleus 
epimysium glued between two pieces of sandpaper with cyanoacrylate and clamped 
between the serpentine jaw faces of a tissue grip. Achilles tendon width and thickness 
were measured optically, and tendon cross-sectional area was estimated using elliptical 
geometry (CSA = 
                             
 
  ). Tendons were pulled to failure in 
displacement control at a constant rate of 0.5 mm/s. During testing, force and 
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displacement data were collected at 200 Hz. The location of failure was observed, and the 
mechanical properties of ultimate force (N), stiffness (N/mm) and energy to failure (mJ) 
were obtained. In addition, ultimate stress (MPa) was derived by dividing ultimate force 
by tendon cross-sectional area.  
 
Figure 3.2. Set-up for the mechanical testing of rat Achilles tendons. A) View 
from above. B) Magnified view of the muscle-tendon-bone complex from above. 
C) Side view. 1— load cell (225N); 2— titanium tissue grips; 3 — computer 
controlled actuator; 4 — serpentine grip surfaces; 5— Achiles tendon; 6 —
calcaneus fixed at 90° to Achilles tendon; 7— Wood’s low melting point alloy 
used to for the calcaneus. 
3.2.6  Gene expression 
A B
C
1
2
2
3
3
4
5
5
6
6
7
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Achilles tendons from 36 female rats (4 wk: n = 9 treadmill running and 9 cage 
control; 10 wk: n = 9 treadmill running and 9 cage control) were removed and prepared 
for quantitative real-time PCR (qRT-PCR). Tendons were ground in liquid nitrogen into a 
fine powder using a mortar and pestle. The frozen tendon powder was further 
homogenized in Trizol
®
 (Invitrogen, Carlsbad, CA) using a Tissue-Tearor
TM
 (BioSpec 
Products, Inc., Bartlesville, OK). Total RNA was extracted from the Trizol-tendon 
powder samples with chloroform and precipitated with isopropanol. The RNA pellet was 
further processed using the RNeasy Plus Mini Kit (QIAGEN, Inc., Valencia, CA) and 
RNA quantity and quality were determined using a NanoDrop 1000 spectrophotometer 
(Thermo Scientific, Waltham, MA). First strand cDNA synthesis was performed with the 
First-Strand cDNA Synthesis Kit (GE Healthcare, Buckinghamshire, UK).  
qRT-PCR primers and probes were obtained from Assays-on-Demand
TM
 (Applied 
Biosystems, Carlsbad, CA) for the following genes: Col1a1 [collagen, type I, alpha a] 
(Rn01463848_m1), Col3a1 [collagen, type III, alpha 1] (Rn01437681_m1), Mmp13 
[matrix metallopeptidase 13] (Rn01448194_m1), Scx [scleraxis] (Rn01504576_m1), and 
Il1a [interleukin 1 alpha] (Rn00566700_m1). TaqMan Universal PCR Master Mix 
(Applied Biosystems, Carlsbad, CA) was used for amplification in a Mastercycler ep 
realplex
2
 real-time PCR system (Eppendorf, Westbury, NY). The qRT-PCR 
amplifications were performed in a sealed 96-well optical plate with the following 
reaction conditions: 2 min at 50°C, 10 min at 95°C, and 40 cycles of 95°C for 15 sec 
followed by 60°C for 1 min. GAPDH (Rn99999916_m1) was used as an endogenous 
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control. Levels of target gene mRNA were expressed as fold change using the ΔΔCt 
method relative to expression from non-injected tendons from cage control animals. 
 
3.2.7  Statistics 
 
Statistical analyses were performed using IBM SPSS Statistics (v20.0; SPSS Inc., 
Chicago, IL) software and were two tailed with a level of significance set at 0.05. Two-
way one-repeated-measure analyses of variance (ANOVA) were used for comparisons, 
with the intrinsic factor (collagenase injected vs. non-injected) being the within-animal 
and the extrinsic factor (treadmill running vs. cage control) being the between-animal 
independent variables. In the event of a non-significant ANOVA interaction, main effects 
for each independent variable were explored. Gene expression data were log transformed 
prior to analysis. Kappa statistics were calculated to measure the inter-rater agreement. 
 
3.3  Results 
 
Animals in the 4 and 10 wk treadmill running groups ran an average total distance 
of 22.6 ± 1.9 km and 58.3 ± 9.7 km, respectively (Figure 3.3; Table 3.2; Table 3.3). There 
were no body mass differences between treadmill and cage control animals at either 4 or 
10 weeks (all P > 0.11; unpaired t-test). There were no statistical interactions between the 
intrinsic and extrinsic factors on any outcome measure (all P > 0.11), indicating treadmill 
running and collagenase injection had independent effects. 
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Figure 3.3. Cumulative distance ran on the treadmill by rats in the run 
group. Error bars represent standard deviation. 
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Table 3.2. Weekly running distances by rats in the 4 week run group. Distances are 
presented in km and maximum represents the maximum possible distance for that week. 
      Rat Week Total 
  1 2 3 4   
1 3.15 5.93 7.35 8.02 24.45 
2 3.15 5.93 7.35 0.00 16.43 
3 3.15 5.93 7.23 7.43 23.73 
4 3.15 5.93 7.23 7.43 23.73 
5 3.15 5.93 7.23 7.43 23.73 
6 3.15 5.93 6.98 7.30 23.35 
7 3.15 5.93 7.23 7.18 23.48 
8 3.15 5.93 7.23 7.30 23.60 
10 3.15 5.93 6.48 6.68 22.23 
11 3.15 5.93 6.23 2.96 18.26 
12 2.63 5.34 7.10 6.55 21.61 
13 3.15 3.41 6.60 7.05 20.21 
14 3.15 5.93 7.23 7.18 23.48 
15 3.15 5.93 7.23 7.43 23.73 
16 3.15 5.93 7.23 6.80 23.10 
17 3.15 5.93 7.23 6.93 23.23 
18 3.15 5.93 7.23 7.43 23.73 
19 3.15 5.93 7.23 6.30 22.60 
20 3.15 5.93 7.23 7.18 23.48 
22 3.15 5.53 7.23 6.68 22.58 
23 3.15 4.93 7.23 7.18 22.48 
24 3.15 5.93 7.23 7.43 23.73 
Maximum 3.15 5.93 7.25 7.43 23.76 
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Table 3.3. Weekly running distances by rats in the 10 week run group. Distances are 
presented in km and maximum represents the maximum possible distance for that week. 
            Rat Week Total 
  1 2 3 4 5 6 7 8 9 10   
1 0.95 5.85 4.99 6.82 3.45 3.49 1.57 3.03 3.15 0.00 33.27 
2 0.16 5.33 6.63 7.23 7.43 7.43 7.82 7.82 8.73 7.23 65.77 
3 0.16 5.33 6.13 5.85 6.68 7.43 6.99 7.82 4.19 7.04 57.59 
4 0.95 5.65 6.90 6.95 6.92 6.55 4.85 2.48 1.50 0.00 42.74 
5 0.55 5.23 5.76 7.23 7.18 7.30 8.09 7.54 7.08 7.79 63.72 
6 0.38 5.33 6.63 7.23 7.43 7.18 6.52 4.93 3.49 0.47 49.56 
7 0.38 1.17 2.60 6.85 7.43 7.18 5.53 5.62 6.33 2.80 45.87 
8 0.95 6.48 7.23 7.43 7.43 7.18 3.42 1.07 2.80 0.00 43.96 
9 0.88 5.33 6.51 7.23 7.43 7.30 7.68 5.07 6.63 2.89 56.91 
10 0.95 6.48 7.23 7.43 7.23 7.23 7.23 7.39 7.43 8.73 67.28 
11 0.95 6.48 7.23 7.43 7.23 7.23 7.23 7.39 7.43 8.73 67.28 
12 0.00 4.11 7.10 7.43 7.43 7.43 4.27 3.75 5.24 0.00 46.74 
13 0.95 6.48 7.23 7.43 6.98 6.98 7.23 7.14 7.18 8.73 66.28 
14 0.95 6.48 7.23 7.43 7.23 7.23 7.23 7.39 7.43 8.73 67.28 
15 0.95 6.48 7.23 7.43 7.23 7.10 7.23 6.39 6.80 7.68 64.48 
16 0.92 6.35 7.23 7.43 7.43 7.43 6.47 5.40 4.90 0.00 53.54 
17 0.95 6.48 7.23 7.43 7.23 7.10 7.23 7.39 7.43 8.73 67.16 
18 0.95 6.48 7.23 7.43 7.23 7.10 7.23 7.39 7.43 8.73 67.16 
19 0.95 6.48 6.35 7.03 7.07 7.30 6.19 6.40 5.85 0.00 53.61 
20 0.95 6.48 7.23 7.43 7.23 7.10 7.23 7.39 7.30 8.73 67.03 
21 0.95 6.48 7.23 7.43 5.93 5.93 5.93 7.43 7.43 8.73 63.42 
22 0.95 6.48 7.23 7.43 5.93 5.93 5.93 7.43 7.43 8.73 63.42 
23 0.91 5.85 6.05 7.13 7.13 7.03 8.04 7.02 7.00 0.00 56.15 
24 0.95 6.48 7.23 7.43 5.93 5.93 5.93 7.43 7.18 8.28 62.72 
25 0.95 6.48 7.23 7.43 5.93 5.93 5.93 7.43 7.43 8.73 63.42 
Maximum 0.95 6.48 7.23 7.43 7.43 7.43 8.09 8.09 8.73 8.73 70.59 
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3.3.1  Histopathological appearance  
 
There were no obvious qualitative differences between Achilles tendons from 
cage control and treadmill running animals at 4 weeks, whereas collagenase injected 
tendons at the same time point demonstrated hypercellularity with rounded tenocytes and 
increased vascularity (Figure 3.3A). Collagenase injected tendons showed higher total 
histopathological scores than non-injected tendons at 4 weeks (P < 0.01) (Figure 3.3B). 
There was no effect of treadmill running on total histopathological score at 4 weeks (P =  
0.41) (Figure 3.3B), and neither collagenase injection (P = 0.29) or treadmill running (P 
=  0.71) influenced total histopathological score at 10 weeks (Figure 3.3C). Scores for 
individual histopathological characteristics are shown in Table 3.4.  
 
 3.3.2  Mechanical properties 
 
 During testing, all tendons failed proximal to their insertion into the calcaneus 
without bone avulsion. There was no effect of treadmill running on tendon cross-
sectional area or mechanical properties at either 4 or 10 weeks (all P > 0.33; Figure 3.4). 
Collagenase injection increased tendon cross-sectional area by 56% and 53% at 4 and 10 
weeks, respectively (all P < 0.01; Figure 3.4A, B). At 4 weeks, collagenase injected 
tendons had 15% and 42% lower ultimate force and stress than non-injected tendons, 
respectively (all P < 0.05; Figure 3.4C, E). Collagenase injected tendons also had 42% 
lower energy to failure (P < 0.05; Figure 3.4G) than non-injected tendons at 4 weeks; 
however, there was no effect of collagenase at 4 weeks on stiffness (P = 0.31, Figure 
3.4I). At 10 weeks, collagenase injected tendons had 13% and 35% less ultimate force  
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Figure 3.4. Collagenase and treadmill running effects on the histological 
presentation of the Achilles tendon. A) Representative photomicrographs of Achilles 
tendons in the 4 week experimental group. Note the well-aligned collagen fibers and 
elongated tenocyte nuclei in the non-injected tendons. Collagenase injected tendons had 
notable changes with highly unorganized collagen fibers, hypercellularity, rounded 
tenocytes, and increased vascularity. B) Average total histopathological scores of tendons 
in the 4 week group. C) Average total histopathological scores of tendons in the 10 week 
group. Bars in C and D represent mean ± SD. There was no collagenase injection x 
treadmill running interaction at either time point (all P > 0.85). There was no main effect 
for treadmill running in the 4 week group (P = 0.58) or main effects for either 
collagenase injection (P = 0.31) or treadmill running (P = 0.43) in the 10 week group). 
*Collagenase injection main effect (P < 0.01). 
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Table 3.4. Collagenase and treadmill running effects on histopathological characteristics. Scores are presented as mean ± SD. 
  
Histopathological 
characteristic Cage control 
 
Treadmill running   
Kappa 
statistic   
P-values 
    Non-injected Collagenase injected   Non-injected Collagenase injected       Collagenase effect Running effect Interaction effect 
4 week 
         
   
 
Collagen arrangement 2.25 ± 0.50 2.25 ± 0.50  
1.20 ± 0.84 2.20 ± 0.45 
 
0.67 
 
0.15 0.07 0.15 
 
Tenocyte morphology 1.25 ± 0.96 1.50 ± 1.00  
0.80 ± 0.45 1.60 ± 0.89 
 
0.92 
 
0.06 0.74 0.29 
 
Cellularity 1.25 ± 0.50 1.75 ± 0.50  
1.20 ± 0.84 1.40 ± 0.55 
 
0.75 
 
0.36 0.41 0.69 
 
Vascularity 0.50 ± 1.00 2.75 ± 0.50*  
1.40 ± 1.34  2.00 ± 1.41*  
 
0.92   0.03 0.9 0.15 
 
Total score 5.25 ± 1.26 8.25 ± 2.22*   4.60 ± 1.95 7.20 ± 1.92*   -  
0.01 0.41 0.81 
  
           
10 week 
 
           
 
Collagen arrangement 1.71 ± 0.95 1.86 ± 0.90  
1.63 ± 0.52 1.50 ± 0.93 
 
0.70 
 
0.98 0.36 0.72 
 
Tenocyte morphology 0.71 ± 0.49 1.00 ± 1.00  
0.75 ± 0.46 1.13 ± 0.83 
 
0.40 
 
0.19 0.79 0.86 
 
Cellularity 1.43 ± 0.53 1.29 ± 0.76  
1.00 ± 0.53 1.50 ± 0.76 
 
1.00 
 
0.50 0.64 0.23 
 
Vascularity 1.14 ± 0.69 1.43 ± 1.51  
0.88 ± 0.99 1.50 ± 1.20 
 
0.75 
 
0.23 0.84 0.65 
  Total score 5.00 ± 1.83 5.57 ± 2.88   4.25 ± 1.83 5.63 ± 3.02   -   0.29 0.71 0.66 
             *Collagenase injection main effect (P < 0.03) 
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and stress than non-injected tendons, respectively (all P < 0.04; Figure 3.4D, F). There 
was no effect of collagenase at 10 weeks on energy to failure (P = 0.31, Figure 3.4H); 
however, collagenase injected tendons had 13% less stiffness than non-injected tendons 
(P = 0.04, Figure 3.4J). 
 
3.3.3  Gene expression 
 
The effects of collagenase injection and treadmill running on gene expression are 
shown in Figure 3.5. Expression levels of Il1a at 10 weeks were undetectable. Treadmill 
running decreased Col3a1 and MMP13 expression at 4 weeks (all P < 0.05; Figure 3.5C, 
E). There was no effect of treadmill running on any other genes at 4 weeks or any genes 
at 10 weeks (all P = 0.06 to 0.98). Collagenase injection increased expression of Col1a1, 
Col3a1, Mmp13 and Il1a at 4 weeks (all P ≤ 0.03; Figure 3.5A, C, E, I). MMP13 
remained elevated in collagenase injected tendons at 10 weeks (P = 0.03; Figure 3.5F). 
There was no effect of collagenase on Col1a1 or Col3a1 at 10 weeks (all P ≥ 0.08; Figure 
3.5B, D), or Scx at either 4 or 10 weeks (P > 0.15; Figure 3.5G, H). 
 
3.4  Discussion 
 
The results of this study indicate that combined introduction of intratendinous 
collagenase injection and uphill treadmill running is unable to create lasting pathology 
within the HCR rat Achilles tendon consistent with chronic Achilles tendinosis in 
humans. Collagenase injection induced molecular, histopathological and  
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Figure 3.5. Collagenase and treadmill running effects on the mechanical properties 
of the Achilles tendon. Bars represent mean ± SD. *Collagenase injection main effect (P 
< 0.05). 
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Figure 3.6. Collagenase and treadmill running effects on the gene expression of the 
Achilles tendon. Levels of total RNA presented as fold expression relative to non-
injected cage control rats. Bars represent mean ± SD. *Collagenase injection main effect 
(P < 0.03). 
†
Treadmill running main effect (P < 0.05). 
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mechanical property changes within the Achilles tendon when assessed at 4 weeks post-
injection.The mechanical changes persisted at 10 weeks following injection; however, the 
histopathological and majority of the molecular changes associated with collagenase 
injection were no longer present at 10 weeks. Treadmill running did not exacerbate the 
collagenase-induced changes as there were no statistical interactions between collagenase 
injection and treadmill running. In fact, treadmill running had minimal effect on the 
Achilles tendon, with the only measureable effects of running being reductions in Col3a1 
and Mmp13 expression at 4 weeks. These early gene expression changes did not translate 
into running-induced histopathological or mechanical property changes. Overall, these 
data suggest that intratendinous collagenase injection had early, partially-reversible 
effects on the Achilles tendon of rats selectively bred for high-capacity running which 
were not influenced by treadmill running.  
 The current data contrast the reported combined effects of collagenase injection 
and treadmill running in a rat model of rotator cuff disease [365,463], but generally 
support those of Godbout et al. [391] who showed voluntary wheel running beginning 7 
days following collagenase injection had no additive effect on rat Achilles tendon 
mechanical properties when assessed at 28 days post-injection. Intratendinous 
collagenase injection in the current study induced early tendon degradation, evident by 
the presence of hypercellularity with rounded tenocytes, increased vascularity and 
mechanical weakening of the tendon at 4 weeks post-injection. These histopathological 
and mechanical changes were coupled with elevated expression of markers for 
inflammation (Il-1a) and tendon remodeling (Mmp13, Col1a1 and Col3a1). As the 
histopathological changes were no longer evident at 10 weeks post-injection, the early 
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collagenase injection effects were partially reversible with the pathology not progressing 
to replicate Achilles tendinosis as observed in humans. The reversibility of intratendinous 
collagenase injection effects in the Achilles tendon is consistent with previous reports 
[390-393]. Superimposition of uphill treadmill running had no synergistic or even 
additive effect on the histopathological or mechanical properties of collagenase-injected 
Achilles tendons, suggesting running was unable to sufficiently overload the intrinsically 
compromised tendons.  
Numerous investigators have previously investigated treadmill running as a 
potential means of mechanically overloading the rodent Achilles tendon [122,146,369-
373]. Some success has been reported in terms of inducing histopathological and 
mechanical changes consistent with human Achilles tendinosis [370,372]; however, these 
data have not been independently replicated and, in one instance, have been contradicted 
by more recent comprehensive data showing treadmill running actually had beneficial 
tendon effects [146]. The absence of a treadmill running detrimental effect on the 
Achilles tendon may relate to the innate ability of rodents to run. Rats are habitual 
runners, and run in excess of 8 km/day in the wild and in voluntary wheel-running studies 
[452,464]. The preference of rats to run may make it difficult to induce overuse tendon 
injuries as their musculoskeletal systems may be inherently adapted to the loads 
associated with running [465]. Inherent adaptation may have been exaggerated in the 
current study by the use of HCR rats which have been selectively bred for aerobic 
capacity. The use of HCR rats enabled us to run our animals at a greater incline (15°) and 
faster pace (up to 30 m/min) than in previous studies, with the belief that these 
parameters would potentiate the generation of Achilles tendon degeneration. However, 
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the study strength of using HCR rats may also be a weakness as the selective breeding of 
our animals for aerobic capacity may also have led to the development of a tendon 
phenotype that further enhanced tendon resistance to degeneration 
 It is possible that the relatively long delay (9 days) between collagenase injection 
and commencement of treadmill running contributed to the absence of an interaction 
between the two interventions. The delay was introduced to allow the initial 
inflammation (tendinitis) response to intratendinous collagenase injection to subside so 
that mechanical loading was being performed on a relatively non-inflamed, but 
intrinsically compromised tendon. Unfortunately, the delay may have ultimately reduced 
the ability to observe an interaction between the intrinsic and extrinsic factors for tendon 
degeneration. This hypothesis is partly support by Godbout et al. [391]. In addition to 
exploring the effects of voluntary wheel running beginning 7 days following collagenase 
injection, Godbout et al. [391] explored the effect of running commenced immediately 
following injection. Combining collagenase injection with immediate access to a running 
wheel, Godbout et al. [391] observed elevated markers of inflammation after 3 and 7 
days, and reduced Achilles tendon mechanical properties at 28 days compared to when 
the interventions were introduced in isolation. These data suggest running commenced 
earlier after collagenase injection may be more effective at advancing Achilles tendon 
degeneration. However, this requires further investigation as it remains unclear whether 
the larger decline in mechanical properties with combined introduction of collagenase 
injection and wheel running in Godbout et al.’s [391] study was due to tendinosis or 
persistent tendinitis as histopathological analyses were not performed and tendons were 
not followed beyond 4 weeks of intervention.  
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The present study had a number of strengths with regards to the development of a 
suitable animal model of Achilles tendinosis. It intrinsically degraded one Achilles 
tendon in relatively old animals (age = 35.5 ± 7.9 wk) prior to running the animals at a 
relatively steeper incline and speed than used in previous studies. The injection of one 
tendon per animal enabled within-animal comparisons to be performed, while the use of 
relatively older animals may have potentiated the development of tendon degeneration. 
Despite these strengths, the study did have limitations beyond those already discussed. In 
particular, the relatively prolonged treadmill acclimation period of 2 weeks after 
collagenase injection and subsequent relatively short period (8 weeks) of running at full 
speed and duration may have facilitated tendon adaptation to running and/or limited the 
ability to progress the initial collagenase-induced pathology. An additional limitation 
may have been the lack of a control injection in the contralateral limb. Khan, et al [378] 
conducted a study utilizing injections into tendons and included three control groups: no 
injection, saline injection, and needlestick only. None of these treatments resulted in 
inflammatory or degenerative changes with light microscopy; therefore, neither the 
volume of the collagenase nor the needlestick is likely the cause of the collagenase effect 
in injected tendons. The current study was also limited by relatively small numbers of 
samples for each outcome measure and the use of animals of different sexes for different 
outcome measures (although all analyses were performed on sex-matched samples). 
 In summary, the results of this study indicate that combined introduction of 
intratendinous collagenase injection and uphill treadmill running is unable to create 
pathology within the HCR rat Achilles tendon consistent with Achilles tendinosis in 
humans.  
 96 
 
CHAPTER FOUR: THE EFFECTS OF UPHILL RUNNING AND COLLAGENASE 
INJECTION ON THE ACHILLES TENDON IN SPRAGUE DAWLEY RATS 
 
4.1  Introduction 
 
 Although several studies have reported pathological changes in the Achilles 
tendon following treadmill running [369,370,373], the previous studies in this 
dissertation did not result in similar changes. The initial study was completed to 
determine if mechanical overuse at higher speeds and greater incline than previous 
studies could produce pathological changes in the histology of the Achilles tendon in 
HCR rats. Similar to Heinemeier, et al. [146], this protocol did not induce 
histopathological changes in the Achilles tendon. 
 To build upon this initial study, the individual and combined effects of an 
extrinsic and intrinsic factor were investigated. This protocol was designed to model the 
three-stage process of pathogenesis of tendinopathy described by Fu, et al. [244]. This 
hypothesis includes an initial injury followed by failed healing, which eventually results 
in clinical presentation of tendinopathy. While this process seems to provide an accurate 
theory for the human pathology, studies investigating this process in animal models are 
limited. Godbout, et al. [391] conducted a study utilizing voluntary wheel running with 
collagenase injection in rats, but this method has yet to be replicated. Therefore, we 
performed intratendinous collagenase injections to mimic the initial injury, followed by 
uphill treadmill running to contribute to the failed healing stage. Additionally, the 
mechanical and molecular changes were investigated along with the histological 
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characteristics in order to provide a more complete description of the effect of this 
protocol. These outcome measures revealed that the combination of uphill treadmill 
running and collagenase injection did not induce pathology in the HCR rat Achilles 
tendon similar to human tendinosis.  
 The aim of the current study was to investigate the individual and combined 
effects of collagenase injection and uphill treadmill running in creating pathology within 
the rat Achilles tendon consistent with Achilles tendinosis in humans. The effects of these 
factors were analyzed by observing the histological properties of Sprague Dawley 
Achilles tendons. The negative results of the previous studies required further 
investigation of the limitations of the protocols in order to determine if these limitations 
were preventing a positive result. The limitations of HCR rats, a long delay between 
collagenase injection and treadmill running, and treadmill acclimation following 
collagenase injection were addressed in the present study by using a different strain of 
rats and adjusting the protocol to minimize any limitations present in the previous studies. 
 
4.2   Methods 
 
4.2.1  Animals 
 
Twenty-five 12 week-old, virgin, female Sprague Dawley rats (weight: 210.3 ± 
8.0 g) were acquired (Harlan Laboratories, Indianapolis, IN) and acclimated for one 
week. All animals were maintained under standard conditions and provided ad libitum 
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access to food and water. All procedures were performed following a priori approval 
from the Indiana University Institutional Animal Care and Use Committee. 
 
4.2.2  Treadmill acclimation 
 
Following the one week acclimation period, all rats underwent 5 days of treadmill 
acclimation, which began with rats running for 20 minutes at 17 m/min and a 15° incline. 
Duration was increased by 10 minutes each day, reaching 60 minutes on day 5. The speed 
and incline were kept constant at 17 m/min and 15°.  
 
4.2.3  Intrinsic factor 
 
At the conclusion of running on the final day of treadmill acclimation, all rats 
received a collagenase injection in their right Achilles tendon to induce preliminary 
tendon changes. Collagenase was prepared by dissolving 100 mg of bacterial collagenase 
type I (Sigma-Aldrich, Inc., St. Louis, MO) in 10 mL of phosphate buffered saline and 
sterile filtering through a 0.22 µm filter. With the animal under inhalation anesthesia, 30 
µL (0.3 mg) of collagenase was injected percutaneously into the right Achilles tendon 2 
mm proximal to the calcaneus using a 50 µL syringe equipped with a 22G needle 
(Hamilton Company, Reno, NV). A one-time intratendinous dose of 0.3 mg of 
collagenase was chosen based on previous work showing this dose consistently induces 
matrix changes, including an initial acute and intense inflammatory reaction coupled with 
collagen disruption followed by progressive tendon healing [390-393]. Left Achilles 
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tendons were not injected and served as non-injected controls. All animals were returned 
to their home cage upon recovery from anesthesia.  
 
4.2.4  Extrinsic factor 
 
 Animals were randomly divided into treadmill running (n = 12) or cage control (n 
= 13) groups after 3 days of normal cage activity following the collagenase injections. 
Rats in the treadmill running group ran 5 days/week for 8 weeks, while rats in the cage 
control group maintained normal cage activity for 8 weeks. On day 1 of the running 
protocol, rats in the treadmill running group ran for 45 minutes at 17 m/min and a 15° 
incline. On day 2, the duration was increased to 60 minutes, where it remained for the 
rest of the study. Speeds were increased by 1 m/min every week throughout the 8 weeks 
of the protocol, reaching 24 m/min in the final week (Table 4.1). Treadmills were 
equipped with an electric shock grid set to 10 Hz. If rats remained on the shock grid for 
more than three seconds, they were manually prodded back onto the treadmill or removed 
from the shock grid and placed onto the treadmill. If this occurred more than five times, 
the rat was removed from the treadmill and allowed to rest until the running session the 
following day. 
 
 4.2.5   Histopatholgical analysis 
 
All animals were euthanized after eight weeks of the running regimen and 
Achilles tendons were harvested and fixed in 10% neutral buffered formalin for 48 hours 
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before being transferred to 70% ethanol. Tendons were embedded into paraffin and 6 µm 
midsubstance sagittal sections were cut using a microtome. Sections were stained with 
hematoxylin and eosin as previously described and additional sections from each tendon 
were stained with alcian blue and counterstained with nuclear fast red.  
 
Table 4.1. Running protocol used for the running group of rats.  
      Duration (min) Speed (m/min) 
Acclimation Week 1 Day 1 20 17 
  
Day 2 30 17 
  
Day 3 40 17 
  
Day 4 50 17 
  
Day 5* 60 17 
Protocol Week1 Day 6 45 17 
  
Day 7 60 17 
  
Day 8 60 17 
  
Day 9 60 17 
  
Day 10 60 17 
 
Week 2 
 
60 18 
 
Week 3 
 
60 19 
 
Week 4 
 
60 20 
 
Week 5 
 
60 21 
 
Week 6 
 
60 22 
 
Week 7 
 
60 23 
  Week 8  60 24 
*Intratendinous collagenase injections were given following running 
 
 
Prior to staining, the alcian blue and nuclear fast red counterstain reagents were 
prepared. To prepare the 1% alcian blue, 97 mL of distilled water was combined with 3 
mL glacial acetic acid, and then 1 g of alcian blue, 8Gx was added. This mixture was 
stirred overnight and adjusted to pH 2.4 by adding glacial acetic acid. Sodium hydroxide 
was added if the reagent became too acidic. Once the pH was correct, the reagent was 
filtered before use. The 0.1% nuclear fast red was prepared by dissolving 5 g aluminum 
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sulfate into 100 mL distilled water, followed by slowly adding 0.1 g nuclear fast red. The 
mixture was heated to a boil and cooled, then filtered. A grain of thymol was added as a 
preservative.  
After preparing the reagents, sections were de-waxed and re-hydrated, then placed 
in the alcian blue solution for 90 minutes. Next, the sections were washed in running tap 
water for two minutes, and then rinsed in distilled water. Sections were then 
counterstained in the nuclear fast red solution for eight minutes and washed in running 
tap water for one minute. Sections were dehydrated through two changes of 95% and 
100% ethanol and cleared in xylene twice. Finally, slides were coverslipped with resinous 
mounting medium. 
All sections were viewed on a Leica DM3000 light microscope (Leica 
Microsystems; Wetzlar, Germany). In addition to the four characteristics previously 
described, ground substance pathology was determined from observation of sections 
stained with alcian blue (Table 4.2). The characteristics were graded between 0 (normal) 
and 3 (maximum pathology). The sum of all five categories gave a normal tendon a score 
of 0 and a tendon with maximum damage a score of 15.  
 
Table 4.2. Semiquantitative scale used to grade tendon ground substance. 
 
 
 
Characteristic Grade 0 Grade 1 Grade 2 Grade 3 
Ground 
substance 
 
 No stainable ground 
substance 
 
 Stainable mucin between 
fibers 
 Discrete bundles 
 
 Stainable mucin between 
fibers 
 Loss of demarcation of 
bundles 
 
 Abundant mucin throughout 
the section 
 Inconspicuous collagen 
staining 
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4.3  Results 
 
Animals ran an average total distance of 41.8 ± 3.5 km during this study (Figure 
4.1; Table 4.3). There were no obvious differences between Achilles tendons from cage 
control and treadmill running animals; however, collagenase injected tendons had notable 
hypercellularity with rounded tenocytes and increased vascularity (Figure 4.2A), as well 
as increased ground substance (Figure 4.2B). These observations were confirmed 
quantitatively with collagenase injected tendons having higher scores than non-injected 
tendons in all of the categories assessed (all P ≤ 0.001). Additionally, the total 
histopathological scores of collagenase injected tendons were higher than non-injected 
tendons (P < 0.001). There was no effect of treadmill running on the individual (all P > 
0.25) or total histopathological scores (P = 0. 37), nor were there any interaction effects 
(all P > 0.19 (Figure 4.2C). Scores for individual histopathological characteristics are 
shown in Table 4.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Cumulative distance ran on the treadmill by rats in the run group. Error 
bars represent standard deviation. 
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Table 4.3. Weekly running distances by rats in the run group. Distances are presented 
in km and maximum represents the maximum possible distance for that week. 
          Rat Week Total 
  1 2 3 4 5 6 7 8   
1 4.85 5.40 5.70 6.00 6.30 6.05 2.88 0.31 37.48 
2 4.85 5.40 5.70 6.00 6.30 4.29 1.38 0.48 34.40 
3 4.85 5.40 5.70 6.00 6.30 6.38 3.91 1.56 40.10 
4 4.85 5.40 5.70 6.00 6.30 6.60 6.90 3.36 45.11 
5 4.85 5.40 5.70 6.00 6.30 6.60 6.90 0.96 42.71 
6 4.85 5.40 5.70 6.00 6.30 6.60 4.49 1.03 40.36 
7 4.85 5.40 5.70 6.00 6.30 6.60 5.87 5.88 46.59 
8 4.85 5.40 5.70 6.00 6.30 6.60 3.45 2.76 41.06 
9 4.85 5.40 5.70 6.00 6.30 6.60 6.90 3.60 45.35 
10 4.85 5.40 5.70 6.00 6.30 5.39 4.60 3.72 41.96 
11 4.85 5.40 5.70 5.80 6.30 6.60 4.95 2.64 42.23 
12 4.85 5.40 5.70 6.00 6.30 6.60 5.75 4.08 44.68 
Maximum 4.85 5.40 5.70 6.00 6.30 6.60 6.90 7.20 48.95 
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Figure 4.2. Collagenase and treadmill running effects on the Achilles tendon. 
A) Representative photomicrographs of Achilles tendons. Collagenase injected 
tendons had notable changes with highly unorganized collagen fibers, 
hypercellularity, rounded tenocytes and increased vascularity (H&E, 200x). B) 
Representative photomicrographs of Achilles tendons stained to observe ground 
substance within the tendon. Note the minimal staining in the non-injected 
tendons and abundant staining in collagenase injected tendons (Alcian blue, 
200x). C) Average total histopathological scores of tendons. Bars represent mean 
± SD. There was no collagenase injection x treadmill running interaction (P = 
0.82) or main effect for treadmill running (P = 0.36). *Collagenase injection main 
effect (p < 0.001). 
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Table 4.4. Collagenase and treadmill running effects on histopathological characteristics. Scores are presented as mean ± SD. 
   
  
  
 
   Histopathological 
characteristic Cage control 
 
Treadmill running 
 
P-values 
  Non-injected Collagenase injected   Non-injected Collagenase injected 
 Collagenase effect Running effect Interaction effect 
Collagen arrangement 0.77 ± 0.93 2.08 ± 0.86* 
 
0.92 ± 0.67 2.25 ± 0.62* 
 <0.001 0.56 0.94 
Tenocyte morphology 0.77 ± 0.60 1.69 ± 0.95* 
 
0.75 ± 0.75 1.17 ± 0.58* 
 0.001 0.25 0.19 
Cellularity 0.54 ± 0.78 1.31 ± 0.48* 
 
0.42 ± 0.79 1.25 ± 0.45* 
 0.001 0.58 0.88 
Vascularity 0.69 ± 1.18 3.00 ± 0* 
 
0.42 ± 0.51 2.83 ± 0.39* 
 <0.001 0.26 0.78 
Ground substance 0.23 ± 0.44 1.85 ± 1.14* 
 
0.08 ± 0.29 1.75 ± 1.22* 
 <0.001 0.63 0.92 
Total score 3.00 ± 1.73 9.92 ± 2.53*   2.58 ± 1.73 9.25 ± 1.86* 
 <0.001 0.36 0.82 
      
 
   
*Collagenase injection main effect (P ≤ 0.001, as determined by two-way, one-repeated ANOVA ) 
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4.4  Discussion 
 
 Similar to the previous studies, neither treadmill running nor the combination of 
treadmill running and collagenase injection resulted in any histopathological changes. 
Collagenase injection in isolation resulted in significantly higher histopathological scores 
than control tendons; however, previous research has found that this effect would have 
healed over time rather than progress into the chronic pathology observed in humans. 
This study was conducted to address the suspected limitations of the former 
studies. One limitation of the previous studies was the use of HCR rats, whose selective 
breeding may have led to the development of a tendon phenotype that further enhanced 
resistance to degeneration. In order to address this limitation, this study was conducted 
using Sprague Dawley rats rather than HCR rats; however, 8 weeks of treadmill running 
in the present study had no histopathological effects on collagenase injected tendons in 
Sprague Dawley rats, suggesting that the strain of animals used in the current study may 
not completely explain the absence of significant findings in the previous studies. 
However, there may be slight differences between the two strains of rats as significant 
differences existed in each of the graded characteristics of Sprague Dawley rats, but not 
HCR rats. Ultimately, it appears difficult to sufficiently run rats to induce measureable 
Achilles tendon damage, with the threshold between beneficial and detrimental Achilles 
tendon loading with treadmill running apparently being beyond reach even in intrinsically 
compromised tendons. 
Another limitation of the previous study was the long delay of nine days between 
collagenase injection and the commencement of treadmill running. In the present study, 
 107 
 
the 8 weeks of treadmill running began only three days following collagenase injection, 
yet this did not create any histopathological effect on the Achilles tendon. 
Finally, the relatively prolonged treadmill acclimation period of two weeks after 
collagenase injection followed by only two or eight weeks of running at full speed and 
duration used in the previous study may have facilitated tendon adaptation to running 
and/or limited the ability to progress the initial collagenase induced pathology. In the 
present study, this was addressed by acclimating the Sprague Dawley rats to the treadmill 
for one week prior to collagenase injection and subsequently increasing them to full 
speed and duration on the fourth day after collagenase injection. This adjustment also 
failed to create an interaction effect on the histological presentation of the Achilles 
tendon. 
 In summary, we were unable to identify histopathological changes in the Achilles 
tendon of Sprague Dawley rats following the introduction of both an intrinsic and 
extrinsic factor. This finding may be a consequence of the inability to mechanically 
overload tendons with forced treadmill running, even those tendons that have been 
intrinsically compromised by previous intratendinous collagenase injection. 
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CHAPTER FIVE: SUMMARY AND FUTURE DIRECTIONS 
 
5.1  Dissertation summary 
 
 Studies in this dissertation investigated the effects of exercise and collagenase on 
the rodent Achilles tendon in attempt to develop an animal model of Achilles tendinosis. 
Previous studies have reported conflicting results using exercise, specifically treadmill 
running, as a means of inducing Achilles tendinosis in rodents. The initial study of this 
dissertation found no histopathological changes in the Achilles tendon of HCR rats 
following nine weeks of mandatory uphill treadmill running. Subsequent studies included 
an initial intratendinous collagenase injection to induce an initial injury that may be 
exacerbated by mandatory uphill treadmill running in both HCR and Sprague Dawley 
rats. Light microscopy, mechanical testing, and molecular analysis all revealed a 
damaging effect of the collagenase injection. While this collagenase effect was apparent, 
it was not consistent with human pathology. In addition, these effects did not consistently 
remain at 10 weeks, which may have been a result of progressive healing rather than 
persistent damage. In contrast, the effects of treadmill running were minimal, as the 
extrinsic factor had no effect on the histology or biomechanics and only the expression of 
two genes. Furthermore, these effects appeared beneficial rather than destructive. 
Additionally, there were no interaction effects between collagenase injection and uphill 
treadmill running in any of the outcome measures which were analyzed.  
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5.2  Strengths and limitations 
 
 Several strengths exist in the studies of this dissertation. First, these studies were 
performed in two different strains of rats, as well as rats of both genders and various ages. 
This variety helps to eliminate uncertainty that the lack of degeneration may be due to the 
age, gender, or strain of the rats used in these studies. Also, several durations of treadmill 
running and cage activity were used, including 4, 8, 9, and 10 weeks, which allows the 
effects of the treadmill running and collagenase to be examined at multiple time points. 
In addition, the series of the studies allowed limitations from one study to be adjusted in 
the subsequent studies in order to minimize the possibility that these limitations were the 
cause of negative outcomes.  Finally, these studies contribute to the ongoing search for an 
acceptable animal model of Achilles tendinosis. While there were no positive outcomes 
of these protocols, the results provide researchers with knowledge that may contribute to 
an eventual successful model.  
 While many strengths exist, there are acknowledged limitations within the studies 
of this dissertation. The most recognizable limitation is the difficulty of mandatory 
treadmill running. Typically, rats began the protocol running for the daily duration with 
little to no rest on the electric shock grids; however, after approximately seven weeks, the 
majority of the rats required manual prodding or removal from the shock grid and 
placement on the treadmill. In addition to lessening the overall time spent running, the 
manual prodding often resulted in an altered gait, which may have prevented the 
appropriate stresses from acting upon the Achilles tendon.  
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The use of male and female rats may have contributed to the limitations of the 
studies. The conclusions of the studies in this dissertation compared outcome measures 
performed in one gender to outcome meaures performed in another gender; therefore, 
gender may have played a role in the results. However, we do not believe this influenced 
conclusions from the studies as minimal changes were observed as a result of treadmill 
running, whether in isolation or combined with collagenase injection. 
The daily distances run by the rats in these studies exceeded the distances of 
previous studies, but may not have been great enough to induce damage to the tendons. 
Rats naturally run long distances in the wild, and thus distances exceeding what rats 
normally run may be required for overuse; however, the distances in these studies do not 
likely reach the status of overuse. It is important to note that using mandatory treadmill 
running to achieve these long distances would require a large amount of time daily, 
which may outweigh any benefits of using the model.  
Finally, the use of rodents rather than large animals may contribute to the lack of 
running effect on the Achilles tendon. Alexander [78] described that one function of 
tendons is reduction of work required of the muscle, but this effect is lessened in smaller 
animals. Biewener and Blickhan [79] examined stresses acting on the gastrocnemius and 
plantaris tendons of kangaroo rats when hopping and found that the stresses are much 
lower than the stresses in wallabies, which demonstrate a similar hopping gait. Because 
the kangaroo rat tendons experience less stress, the tendons stretch very little while the 
muscles undergo substantial lengthening and shortening as the ankle bends and extends. 
In larger animals, including humans, the tendons do more stretching and recoiling, likely 
making the tendons more susceptible to damage than the tendons of smaller animals. 
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While this is suggested as a limitation, little research exists on this effect. Also, valid 
rodent models have been established for other tendons, which further negate the 
hypothesis of this effect being a limitation. In addition, using large animals to maximize 
tendon stresses would add to the difficulty and expense of investigating Achilles 
tendinopathy.  
 
5.3  Future directions 
 
 These studies found that neither the individual nor the combined effects of uphill 
treadmill running and intratendinous collagenase injections resulted in an animal model 
of Achilles tendinosis that mimics the human condition. Future research must focus on 
replicating models that other laboratories have reported as successful or conducting new 
studies with alterations to protocols that have been unsuccessful, including those included 
in this dissertation.   
 One model that requires further investigation is rodent bipedal downhill treadmill 
running proposed by Ng, et al. [372]. This method involves suspending the upper bodies 
of rats from harnesses while running, ensuring that all loading is placed upon the hind 
limbs. The initial study reported histological and biomechanical changes which 
resembled the pathological changes of human Achilles tendinosis. While this model 
interferes with the natural gait of the rat, it may allow insight into the molecular changes 
occurring during the pathological process and may allow for pharmaceutical interventions 
to be tested. However, follow-up studies are lacking, and thus the credibility of this 
model is not confirmed.  
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 The studies of this dissertation may also be adjusted in several ways in the search 
for an appropriate animal model. First, rather than mandatory treadmill running, running 
wheels could be provided in the rat cages and voluntary wheel running may be measured. 
This may increase the distance the rats run during the duration of the study and may 
approach distances run in the wild. However, this may be limited by pain from the 
injections prohibiting rats from running. Godbout, et al. [391] found in a four week study 
that animals receiving injections ran on a wheel significantly less than non-injected rats 
during the first week after injection, but all rats ran similar amounts during the final three 
weeks. Additionally, it is unlikely that rats would voluntarily run to the point of overuse. 
If voluntary running is unsuccessful, a combination of voluntary wheel running and 
mandatory treadmill running could be tested. 
 If all running is shown to be unsuccessful, intratendinous injections may be 
combined with electrical muscle stimulation, which produces flexion and extension, and 
thus loading of the tendon. Because animals are under anesthesia during this stimulation, 
the amount of loading can be controlled and optimized, allowing for a greater potential 
for overuse to occur.  
 In addition to adjustments of the extrinsic factor, the intrinsic factor may also be 
altered. One change may be to increase the number of collagenase injections by giving a 
second collagenase injection at the midpoint of the study. This would likely reverse any 
healing that had begun, but may be detrimental to the tendon and induce rupture. Also, 
different injections may be used in attempts to induce degeneration. For example, 
preliminary studies injecting prostaglandins into the tendon have reported an initial effect 
of acute inflammation which progressed to fibrosis of the paratenon and intratendinous 
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degeneration after receiving weekly PGE1 injections for 35 days [377]. One downfall of 
testing other injections is the limited number of existing studies. Because of the lack of 
use, initial studies would have to be performed in order to establish proper dosage 
amounts and schedules. 
 In conclusion, this dissertation provides insight into the individual and combined 
effects of uphill treadmill running and intratendinous collagenase injection on the rodent 
Achilles tendon. The outcomes of these studies, while negative, provide further evidence 
of the complexity that exists in tendon pathology. Although these protocols did not 
produce the desired effect on the Achilles tendon, they may be altered in ways to 
contribute to an acceptable animal model of Achilles tendinosis.  
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APPENDIX: REPRESENTATIVE PHOTOMICROGRAPHS OF THE GRADED 
HISTOLOGICAL CHARACTERISTICS 
 
 
 
 
 
 
Collagen arrangement Tenocyte morphology
Grade 0
Grade 3
Grade 2
Grade 1
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Cellularity Vascularity
Grade 0
Grade 3
Grade 2
Grade 1
No tendons received this 
grade
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Ground substance
Grade 0
Grade 3
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